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I. INTRODUCTION 
The Relevance of Genetics to Medicine 
This issue of the MCV Quarterly focuses on the 
explosion of knowledge in the field of human genet-
ics. The activities of the new Department of Human 
Genetics at the Medical College of Virginia encom-
pass the traditional medical school triad of teaching, 
patient care, and research, and an active graduate 
program has been developed with curricula leading 
to masters and doctorate degrees. The program is 
supported by a recently awarded National Institutes 
of Health predoctoral training grant as well as State 
and local funds from the A. D. Williams Foundation. 
Clinical services are provided in a National 
Foundation-March of Dimes Genetic Counseling 
Clinic and through an interdepartmental Antenatal 
Diagnosis Program. At present, however, as shown 
by some of the case reports in this issue, resea rch and 
clinical service are inextricably intertwined. 
There has, perhaps, been no recent advance in 
medical technology that has greater potential for im-
proving the human condition than the development 
of reliable methods for the prenatal diagnosis of a 
growing list of specific genetic diseases. The Ante-
natal Diagnosis Program at MCV has been devel-
oped with suppport from the State Department of 
Health and has at its disposal the most modern" 
equipment available for these test procedures. N eo-
n a ta I screening for genetic disease and carrier detec-
tion programs are two logical complements to pre-
natal diagnosis. 
It is becoming increasingly clear that the major 
causes of morbidity and mortality in Western cul-
tures a re neither entirely environmental nor genetic 
in etiology but result , rather, from an interaction be-
tween the host and a pathogenic agent in a constantly 
changing environment. The concept of genetic risk 
factors may well emerge as the most significant and 
effective new health care strategy to appear during 
the last quarter of this century. Experience with the 
treatment of genetically determined metabolic dis-
eases suggests that when a specific genetic liability 
can be diagnosed, patients and their parents are in 
general highly motivated to comply even with ex-
tremely elaborate treatment regimes. Wouldn't an 
individual who had seen a parent or close relative die 
of hypertension, heart disease, cancer, or pulmonary 
disease have a strong motivation to comply with a 
program of presymptomatic screening and treatment 
if he or she could be shown to carry a specific genetic 
risk factor? Improved public education will be essen-
tial for the acceptance of this approach to disease 
prevention. Since all normal individuals carry abnor-
mal recessive genes, the diagnosis of a genetic disease 
or carrier state in a family should not be viewed as a 
stigma but rather as a readily identifiable risk factor 
that can be exploited by the prudent physician to plan 
a highly individualized health maintenance program 
for the patient. At present, relatively few alleles have 
been identified which can be detected in the hetero-
zygous state that are associated with an increased 
disease risk; however, the number is growing, and it 
seems likely that this will continue to be a very active 
area of research in the future. 
Genetic diseases are estimated to account for 
15% of all pediatric hospital admissions. Recogniz-
able chromosome abnormalities account for more 
than 50% of all early spontaneous first trimester abor-
tions. A single genetic disease, Usher syndrome, ac-
counts for more than 60% of all adults seeking reha-
bilitative services for the combined handicap of 
deafness and blindness. The lifetime cost of caring for 
the 3,000 to 4,000 new children who a re born each 
year with Down syndrome is estimated to be in excess 
of $60,000,000 per year. More than 2,000 genetic dis-
eases have now been described, most within the past 
two decades, and at least one genetic locus has now 
been mapped to each of the 23 pairs of chromosomes, 
most within the past two years. These facts presage 
the increasingly important role that genetics will play 
in medicine and hum an affairs in future years. 
WALTER E. NANCE, M.D., PH.D. 
Professor of Human Genetics; Pediatrics, and Medi-
cine 
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. II. HISTORY 
The Growth and Development of Genetics 
atMCV 
J. IVES TOWNSEND, PH.D., Associate Professor of Human Genetics 
Genetics was well established at the Medical 
College of Virginia by the time I joined the faculty in 
1960. At least one course in genetics was required of 
students in the Schools of Medicine, Dentistry, Phar-
macy, and Nursing. The Department of Biology and 
Genetics, which was in the School of Pharmacy and 
chaired by Dr. Roscoe D. Hughes, also had a modest 
graduate program in genetics and two genetics re-
search programs, one on facial growth in twins, sup-
ported by a grant from the National Institutes of 
Health , and the other on the genetics of drosophila, 
supported by the National Science Foundation. 
In 1938, Dean Wortley Fuller Rudd of the 
School of Pharmacy had hired Dr. Hughes to teach 
general biology and comparative anatomy to the un-
dergraduate pharmacy students. Dr. Hughes, a grad-
uate of the US Naval Academy at Annapolis, had 
just received his Ph. D. degree at Columbia Univer-
sity for cytogenetic studies on drosophila under the 
tutelage of the distinguished cytologist, Franz Schra-
der; this was the same department in which the Nobel 
Prize winner, Thomas Hunt Morgan, had begun his 
pioneer work three decades earlier. Dr. Hughes had 
the added advantages of direct association with Mor-
gan and other great geneticists, including Leslie C. 
Dunn and Calvin B. Bridges. 
It is hardly surprising then that after his arrival 
at MCV, Dr. Hughes wanted to introduce genetics 
into the various professional curricula; however, ex-
cept for simple Mendelian principles taught in the 
This is paper #42 from the Department of Human Genetics of 
the Medical College of Virginia. 
Correspondence and reprint requests to Dr. J. Ives Townsend, 
Box 33, Medical College of Virginia, Richmond, Virginia 23298. 
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general biology course to pharmacy and nursing stu-
dents, no opportunities arose until sometime after 
World War II. By the late 1940s, the controversy over 
the dangers of fallout from atomic bomb tests had 
made the general public as well as clinicians aware 
that genes affect the health of everyone and undoubt-
edly helped to create the opportunities that Dr. 
Hughes had been looking for. Dr. Hughes 1 reported, 
"Beginning in 1949, three or four lectures in genetics 
were given to second-year dental students. The num-
ber gradually increased to eleven. In 1954, the course 
was placed on a formal basis and from then on car-
ried academic credit. Also, during this period occa-
sional lectures were given on special topics to other 
classes." This was, I believe, the first required ge-
netics course in a dental curriculum anywhere. 
Medical Genetics first appeared as a required 
eleven-hour course in the MCV Bulletin, Winter, 
1951 . While this was probably not the first required 
genetics course in a medical curriculum, it was cer-
tainly among the first. Genetics remains a required 
subject in the Schools of Medicine and Dentistry. 
In 1953, Marion Waller, now Professor of Medi-
cine at MCV, received the first graduate degree to be 
earned in the Department of Biology. As has been 
true of a ll research conducted in that department or 
in one of its successors, her research was in genetics. 
The next year, Dr. Bertram L. Hanna, a mathe-
matical geneticist, joined the faculty of the depart-
ment, doubling the number of faculty above the rank 
of Instructor . Expansion of genetics courses in the 
various professional schools led to the department 
being renamed, Department of Biology and Genetics. 
(Although this name appeared in the MCV Bulletin 
for years beginning in April, 1956, Dr. Hughes once 
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told me that he amended the name himself and soon 
everyone followed his lead without there ever having 
been any official approval.) 
In 1963, the department was offering nine 
courses in its graduate program. By the fall of 1965, 
there were seven genetics graduate students in resi-
dence; this number had risen to nine by the fall of 
1972. 
After MCV and Richmond Professional Insti-
tute merged to form Virginia Commonwealth Uni-
versity in 1968, and Dr. Hugh es retired in I 970, the 
responsibility for teaching anatomy to the pharmacy 
students was assigned to the Department of Anat-
omy; the Department of Biology and Genetics had 
become, in effect, a department of genetics. The 
newly appointed president of VCU, Dr. Warren W. 
Brandt, decided, however, that four faculty members 
were too few to constitute a "viable" department; so 
the department's name was changed to Program in 
Human Genetics, and the program was transferred to 
the School of Basic Sciences and in 1974, moved from 
McGuire Hall to the eleventh floor of Sanger Hall. 
Although the genetics faculty has ceased having 
any role in the education of undergraduate pharmacy 
students, it has maintained responsibility for lectures 
on the genetics of special pathological conditions dis-
cussed in Nursing Health Science. Lectures on appro-
priate genetics topics are still given in the dietetic 
intern program and to students in blood banking. 
Because a study2 made by the Virginia State 
Council of Higher Education in 197 I considered the 
number of graduate degrees earned in the Program in 
Human Genetics at MCV to be too few, the VCU 
administration approved a plan to expand the pro-
gram at the earliest opportunity. Implementation be-
gan when Dr. Walter E. Nance was recruited as 
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Chairman in September 1975. There shortly followed 
the third name change to succeed Department of 
Biology-Department of Human Genetics. 
Since 1975, rapport with clinical departments 
has been strengthened, especially with the Depart-
ment of Pediatrics, which had been closely involved 
with the Program in Human Genetics, and with the 
Department of Obstetrics and Gynecology, which 
had not. Faculty joint appointments have been made 
to several clinicians who have especial interest in 
genetics and are involved in teaching clinical genetics 
or in sponsoring graduate students in genetics. 
In addition, both the space occupied by Human 
Genetics in Sanger Hall and the number of graduate 
students in the Department have doubled; the num-
ber of nonprofessional employees in the Department 
has grown more than sixfold; the amount of external 
grant support awarded to the Department's faculty 
has increased to more than $600,000 per year; and the 
Department has received a predoctoral training grant 
from the National Institutes of Health which will 
provide stipends for six students. During the coming 
year two additional faculty members will be re-
cruited, increasing to six the number with primary 
appointments in Human Genetics. After the benign 
neglect of genetics, these developments promise to 
fulfill the dream of having an outstanding human 
genetics center at MCV, a dream long held by MCV's 
first geneticist, Dr. Hughes. 
REFERENCES 
I. HUGHES RD: Genetics in the dental curriculum, in Witkop CJ 
Jr (ed.): Genetics and Dental Health. New York, McGraw-Hill 
Book company, 1962, pp 281-284. 
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Ill. PRENATAL DIAGNOSIS PROGRAM 
Indications for Antenatal Genetic Diagnosis 
FAY REDWINE, M.D., Assistant Professor of Obstetrics and Gynecology and of Human Genetics 
ROBERT. E. PETR ES, M .D., Associate Professor of Obstetrics and Gynecology 
The diagnosis of chromosomal and metabolic 
abnormalities by mid-trimester amniocentesis is now 
an established part of antenatal care. Jacobson pub-
lished the first use of this technique in 1967,1 followed 
in 1968 by Nadler. 2 By 1974, over 3,000 pregnancies 
had been studied permitting the prenatal diagnosis of 
a wide variety of chromosomal anomalies and more 
than 60 different inborn errors of metabolism during 
the second trimester of pregnancy at a time when 
termination of the pregnancy can be safely performed 
if an abnormality is detected . During this period, the 
National Institute of Child Health and Human De-
velopment established a Nation al Registry for am-
niocentesis in an attempt to document the safety and 
accuracy of this technique. Its report was published 
in 1975 and dealt with a comparison of 1,040 preg-
nancies studied by mid-trimester amniocentesis and 
992 matched control pregnancies.3 The conclusions 
from the study were that mid-trimester amniocentesis 
was a safe procedure when performed by a qualified 
physician and that the accuracy rate of antenatal 
genetic diagnosis was 99.4%. Since 1975, the use of 
this procedure has become almost routine in preg-
nancies at risk for identifiable genetic abnormalities 
because of maternal age or family history. It should 
be emphasized that in the vast majority of cases pre-
natal genetic diagnosis is a life-saving procedure. 
Many women who are at high risk would not choose 
to continue their pregnancy unless they could be as-
sured that there is no detectable fetal abnormality . In 
This is paper #41 from the Department of Human Gen etics of 
the Medica l College o f Virginia and was supported in part by a 
Developmental Disabilities Grant from the Department of Mental 
Health and Menta l Reta rdation of the Commonwealth of Virginia. 
C orrespondence and reprint requests to Dr. Fay Redwine, 
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the series of 1,040 amniocentesis procedures men-
tioned above, only 34 abnormalities were detected; of 
these, 27 women elected to terminate their pregnancy. 
In addition, 11 male fetuses were identified among 
the 21 at risk for X-linked disorders and 8 of these 11 
women elected to terminate their pregnancies. 
Because the number of qualified laboratories is 
limited, the cases which can be studied must be re-
stricted to certain high-risk categories. The largest 
group of pregnant women at increased risk of pro-
ducing an abnormal child are patients over 35 years 
of age. It is well established that as the mother ages , 
the incidence of nondisjunction in her gametes in-
creases. Table I shows the relation between the in-
cidence of trisomy 21 and maternal age. Another 
indicator of the effect of maternal age is that while 
only 13% of pregnancies occur in mothers over 35 
years old , these pregnancies produce 51 % of all cases 
of Down syndrome. Recent studies employing nor-
mal chromosomal markers4 have clearly shown that 
the extra chromosome in this syndrome is not in-
variably maternal in origin. If only those cases in 
which the nondisjunction occurred in the mother 
were considered, it seems likely that a more striking 
relationship to the maternal age would be observed . 
Age 35 is considered by many to be the maternal age 
at which the risk is sufficiently great to recommend 
amniocentesis, but this figure is obviously somewhat 
arbitrary . 
The second largest group of patients for whom 
antenatal diagnosis is recommended are women who 
have already had a child with trisomy 21 . The risk of 
producing another mongoloid child in this group is 
I% to 2%. Needless to say, these mothers are also 
extremely anxious about a recurrence, and in most 
cases the results of the cytogenetic analysis serve to 
all ay their fears. 
MCV QUARTERLY 13(4): 140-143, 1977 
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TABLE I 
Relation of Maternal Age and Chromosome Abnormalities 
Maternal 
Age 
10-14 
15-19 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
Distribution 
of mothers 
of children Risk of chromosome 
Distribution with abnormality by 
of total chromosome age group 
sample abnormality 
(%) (%) N Percentage 
0.4 0 0/ 19 
11.0 5.3 1/ 490 0.20 
34.4 42.4 8/ 1531 0.52 
32.0 21.2 4/ 1423 0.28 
14.3 5.3 1/635 0.16 
6.2 21.2 4/ 277 1.44 
1.4 5.3 1/ 62 1.61 
.07 0 0/ 3 
Distribution of materna l ages. N = number of abnormalities 
divided by number in age group. 
A small group of patients at considerable risk for 
chromosomally abnormal children are families in 
which one of the parents carries a chromosomal 
translocation . In these cases, the risk varies depend-
ing on the translocation . For example, in the case of a 
t(2 l ;21) carrier, the risk of bearing a mongoloid child 
is 100%; while in the case of the more common DI G 
translocation t( 15;2 l ), the risk of producing a child 
with translocation Down syndrome varies from 
about 10% to 30% depending upon whether the father 
or the mother is the translocation carrier. This trans-
location group is responsible for "familial mon-
golism" and is fortunately quite rare. Of all mongol-
oid children, 2% to 3% are of the translocation type; 
of these, only about half are familial and the remain-
der are de novo translocations. 
Approximately 150 genetic diseases have been 
recognized which show an X-linked pattern of trans-
mission, and many such as the X-linked hemophilias, 
Duchenne-type muscular dystrophy, and agam-
maglobulinemia are associated with serious or even 
lethal disease . X-linked disorders only affect male 
offspring, although carrier females may occasionally 
show mild symptoms. Specific intrauterine diagnosis 
is not yet possible for most X-linked traits; however, 
since it is possible to diagnose the sex of the child in 
utero, carrier females can avoid giving birth to addi-
tional affected males if they are willing to carry only 
female infants to term . Some couples find this an 
acceptable method of completing their families with-
out the fear of a recurrent abnormality; others do 
not. In any case the decision about whether or not to 
use this approach is made by the parents themselves. 
The dilemma of terminating potentially normal preg-
nancies would be solved if specific tests were available 
to diagnose each X-linked disease. Currently, this is 
possible only for a relatively few X-linked diseases in 
which the specific enzymatic defect has been identi-
fied . These conditions include Hunter syndrome, the 
Lesch-Nyhan syndrome, and Fabry disease. In addi-
tion, approximately 40 rare autosomal recession 
traits are known in which the enzyme defect can be 
detected with varying reliabilities in fibroblasts. 
The last category of patients at risk for specific 
fetal abnormalities are those who have had a previous 
child with a neural tube defect (anencephaly, enccph-
alocele, meningomyelocele, and spin a bifida ). As a 
group, the recurrence rate for any of these disorders 
is about 5%.5 These abnormalities are not chromo-
somal defects, therefore, the fetal karyotype is not 
useful. However, it has been well proven that the level 
of alpha-fetoprotein in the amniotic fluid at 16 to 18 
weeks gestation correlates with these defects; a high 
level of alpha-fetoprotein (greater than 5 standard 
deviations above normal) is diagnostic of an open 
neural tube defect. Amniography, fetoscopy, and ul-
trasound can also be utilized to document these ab-
normalities. 
In summary, the general indications for amnio-
centesis for prenatal diagnosis are as follows: 
I. Maternal age greater than 35 years at time of 
conception. 
2. History of a previous child with Down syn-
drome or any other trisomy. 
3. Documented chromosomal translocation in 
either parent. 
4. Previous child with a serious inherited X-
linked disease or an autosomal genetic disease 
that can be detected prenatally. 
5. Previous child with a midline neurologic de-
fect. 
Table 2 is a summary of the indications for am-
niocentesis performed at MCV since 1973. 
Patients who have been counseled and have a 
definite indication for prenatal genetic diagnosis, and 
who have given their informed consent, are first 
scheduled for an ultrasound examination. This non-
invasive scanning procedure can locate the placenta, 
identify the best area for the amniocentesis, and rule 
out twin gestations. It also accurately measures the 
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TABLE 2 
Indications for Prenatal Diagmisis at MCV 
(9-1-73 to 7-1-77) 
28 Previous trisom y 21 
77 Maternal age 40 yr o r greater 
65 Maternal age 35 yr to 39 yr 
8 Close reiati ve with trisomy 21 
Previous child with hemophili a A 
I Previous spina bifida + cleft palate 
IO Previous spina bifida or hydrocephalus or meningocele 
22 Previous anencephalic 
I Previous Potter syndrome 
2 Anophthalmia 
Previo us GI G translocation carrier 
Previous DIG translocation carrier 
Elevated maternal creatine phosphokinase 
Previous child with Sandhoff disease 
Four previous spontaneous abo rtions 
Previous trisomy 18 
Previous trisomy 13 
Previo4s XX / XO mosaics 
I Three previous "retarded" children 
2 Previous child with "multiple defects" 
fetal head to document fetal age. After the ultrasound 
procedure, the patient's abdomen is prepared and 
under sterile conditions the amniocentesis is per-
formed by an experienced obstetrician. The amnio-
centesis procedure involves the introduction of a 
small bore needle through the mother's abdominal 
wall into the uterus and amniotic cavity under local 
anesthesia. The ultrasound examination ilids in se-
lecting the proper placement of the needle to avoid 
the b<1by and to locate the amniotic fluid . Twenty 
milliliters of fluid are withdrawn and the needle re-
moved . Most patients have no ill effects from the 
procedure and can go home shortly after it is per-
formed. The optimum time to obtain the amniotic 
fluid is from 15 to 16 weeks gestation . 
Preliminary results are usually available within 
three weeks of the procedure and the final report is 
issued one to two weeks later. 
Since most of the patients have a rate of below 
5% of bearing an affected child, the results are usually 
that the fetus has a normal chromosome com-
plement. This greatly relieves the parents' anxiety and 
allows them to have a happy prenatal course and 
enjoy ;i normal baby. If, however, a mongoloid fetus 
or a fetus with anencephaly is diagnosed, the parents 
are counseled and pregnancy termination suggested. 
This decision is left to the parents once the facts are 
presented to them, and even for those parents who 
TABLE 3 
Medical College of Virginia Results of Antenatal Diagnosis 
(9-1-73 to 7-1-77) 
R ESULTS 
92XXXX 
46XY 
46XX 
45XY-D-G + DI G 
45XO 
47XY + G 
47XX+G 
47XXX 
Normal alpha-fetoprotein 
Abnormal alpha-fetoprotein 
NUMBER 
104 
84 
I 
I 
2 
21 
I 
felt before the study that there would be no question 
of terminating the pregnancy if the fetus were abnor-
mal, the decision is a difficult one. 
As of July I, 1977, at MCV, three patients, of 
216 studied, have been diagnosed with trisomy 21 in 
utero. All three patients underwent therapeutic abor-
tion . In addition, the diagnosis of a fetus with Turner 
syndrome (45XO) was made and the parents elected 
to continue the pregnancy since the abnormality de-
tected was not life-threatening. Table 3 summarizes 
the results of the antenatal testing at MCV. 
The future of antenatal genetic diagnosis is an 
exciting one. Recent advances include the application 
of chromosomal banding te~hniques to identify 
subtle abnormalities and rearrangements; ultraso-
nography, using high resolution gray scale equipment 
to permit delineation of fetal soft tissue and skeletal 
anomalies; and fetoscopy , using a small fiberoptic 
instrument to view the fetus directly and observe its 
development. With the~e ad~ances in technology, it 
should be possible to enable even more women at 
high risk for genetically diseased offspring to bear 
healthy children. 
Table I is adapted from Science (169:495-497, 1970). 
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Recent Advances 1n Cytogenetic Technology 
for Antenatal Genetic Testing 
JUDITH A. BROWN, PH.D., ANNA CARR, ELIZABETH S. COOPER, AND 
DEBORAH W. HERITAGE, Cytogenetic Laboratory, Department of Human Genetics 
The examination of human chromosomes has 
been a part of the physician's laboratory armamen-
tarium since the correct diploid number of human 
chromosomes was established' and a method was 
developed2 for the in vitro growth of peripheral blood 
leukocytes to yield metaphase chromosomes. The 
discovery3 that on ultraviolet microscopy (UV), 
metaphase chromosomes stained with ftuorochrome 
dyes displayed a characteristic pattern of bright and 
dull bands unique for a given pair of homologous 
chromosomes, was a major technological break-
through in human cytogenetics; for the first time, 
every chromosome in the karyotype could be un-
equivocally identified . Although the short storage life 
of ftuorochrome-stained chromosomes and the costs 
of UV microscopy have limited the usability of fluo-
rescence banding, the introduction of one discrimina-
ting procedure quickly led to the development of an 
array of similar banding techniques for conventional 
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microscopy that yield comparable information. Some 
of these technical procedures depend on enzyme and/ 
or heat denaturation of the chromosomes, resultiri~ 
in the characteristic banding patterns seen by the 
trypsirt-Giemsa method,4 the 5M urea method,5 and 
the acid-saline-Giemsa technique.6 A typical human 
karyotype prepa red from metaphase chromosomes 
treated with trypsin, stained with Giemsa, and photo-
graphed with brightfield photomicrographic tech-
niques is shown in Figure I. Careful examination of 
this karyotype reveals that each chromosome in the 
homologous pair has an array of dark and light 
bands identical with those of its homolog and that 
each homologous pair, autosomes number I to num-
ber 22, has a characteristic, easily identifiable band-
ing pattern. 
In order to establish a standardized nomencla-
ture to describe the chromosomes and chromosome 
regions, as revealed by the banding techniques, a 
committee of international experts in human cyto-
genetics met in Paris, France, in 1971.7 The com-
mittee retained the previously established designation 
of the short arm of the chromosome as "p" and the 
long arm as "q" and agreed to divide the chromo-
some arms into a number of regions according to the 
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Fig I-Normal female karyotype. Chromosomes were treated 
with trypsin and stained with Giemsa. (Chromosome magnifica-
tion, X4000.) 
position of the centromere and the banding charac-
teristics of the arm. For example, the long arm of 
chromosome 7 (7q) (Fig I) consists of three regions 
(I to 3) which are more or less delimited by the two 
major dark bands and the lighter staining terminal 
band. If a patient has a deletion in the long arm of 
this chromosome beginning with the second dark 
band from the centromere and including all the rest 
of the long arm to its terminus (ter), the designation 
would be del (7) (pter _, q2 l: ). Such a detailed de-
scription of the karyotype abnormality makes it pos-
sible to associate the physical abnormalities of a 
given patient with a given chromosome abnormality 
and thus establish the phenotype-karyotype correla-
tions which are extremely important in the diagnosis 
of the so-called chromosome syndromes. 
Major indications for a karyotype examination 
are the evaluation of a newborn with multiple con-
genital abnormalities, psychomotor retardation of 
unknown etiology, or ambiguous genitalia; of an 
adolescent with short stature and/ or delayed pub-
erty; of selected cancers such as chronic myelogenous 
leukemia, retinoblastoma, and cancer of the bladder; 
of patients with a history of multiple spontaneous 
abortions or infertility; and of high-risk pregnancies 
by antenatal genetic testing. Whenever one of the 
above conditions occurs, aberrations in the chromo-
somes are a frequent finding . Recently completed 
newborn surveys show that approximately I% of all 
live-born children have a significant chromosome ab-
normality which leads to severe physical and mental 
handicap. Chromosome studies of fetal tissues ob-
tained from early spontaneous abortions clearly in-
dicate that karyotype abnormalities are a contrib-
uting factor in more than 50% of cases . 
The utilization of chromosome banding proce-
dures in antenatal genetic testing has resulted in a 
more accurate description of the fetal karyotype and 
increased diagnostic capabilities. Heretofore, it was 
possible only to document the existence of an abnor-
mal number of chromosomes-a condition known as 
aneuploidy-as found in Down syndrome, 0-tri-
somy, or E-trisomy, while major or minor structural 
aberrations went undetected. At the same time, 
greater expertise in the interpretation of the kar-
yotype result is demanded, and frequently chromo-
some studies of the parents are essential for a correct 
interpretation of the cytogenetic findings in the fetus 
(Figs 2 through 4 ). The fetal karyotype in Figure 2 
shows two chromosomes, chromosome 15 and 
chromosome 21 , with a considerable amount of extra 
chromatin in the short arm (indicated by arrows), 
which can easily be construed as an abnormality. 
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Fig 2-Karyotype of a male fetus. Extra chromatin on the short 
arm of chromosome 15 and of chromosome 21 is indicated by 
arrows. (Chromosome magnification , X4000.) 
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Fig 3-Karyotype of mother showing the polymorphic chromo-
some 21. (Chromosome magnification , X4000.) 
Examination of the parental karyotypes shows that 
the mother (Fig 3) possesses the variant chromosome 
21 and_ the father (Fig 4) the variant chromosome 15. 
These chromosomal differences, referred to as nor-
mal or polymorphic variants, are often seen in hu-
mans with a frequency that depends on the particular 
chromosome; they are compatible with clinically nor-
mal phenotypes . The fetal karyotype in Figure 2, 
therefore, is normal. Another kind of polymorphism 
which can confuse the correct interpretation of a fetal 
karyotype is centromeric heterochromatin (Fig 5 ). In 
this case, one of the homologs of chromosome pairs 
I, 9, and 16 is larger than its normal .homolog-that 
is, heteromorphic-and the size difference can be at-
tributed to a larger amount of inactive chromatin-
heterochromatin as revealed by an alkali treatment of 
the chromosomes, developed by Arrighi and Hsu.8 
These so-called C-band polymorphisms are encoun-
tered in the normal population with a frequency that, 
depending on the chromosome, shows characteristic 
racial distributions . 
The in vitro culture of amniotic fluid cells for 
antenatal genetic testing can be complicated in ap-
proximately I% of cases by contamination of the 
culture with cells of maternal origin. Here, whereas 
fetal cells can be readily discriminated if the fetus is 
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Fig 4-Karyotype of father showing the polymorphic chromo-
some 15. (Chromosome magnification , X4000.) 
15 
' ' 
,, 
19 20 
3 4 
g~ 'a t 
16 17 
.... • , 
21 22 
, . 
"' 5 
' v 
xx 
Fig 5- Normal female karyotype . Chromosomes were treated 
with 0.07N sodium hydroxide and stained with Giemsa . Centro-
meric heterochromatin is indicated by arrows. (Chromosome mag-
nification, X4000.) 
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Fig 6-Chromosomes 4 from four different cells of newborn de-
scribed in text. Arrows indicate the location of the small deletion. 
(Chromosome magnification, X4000.) 
male, a knowledge and use of chromosome poly-
morphisms is used when the fetus is female to rule out 
the presence of maternal cells and assure that the 
karyotype is fetal. This technical difficulty can further 
be circumvented by establishing two or more cultures 
from the amniotic fluid sample and subculturing the 
cells at least once prior to karyotype evaluation. As-
saying duplicate cultures also increases the accuracy 
of the test where chromosome mosaicism may result 
in an abnormal offspring. 
The application of chromosome banding tech-
niques has vastly increased the precision with which 
structural rearrangements can be characterized. This 
in turn has contributed to the mapping of specific 
genes to specific regions and bands of the chromo-
some and has led to the recognition of a growing 
number of syndromes resulting from small dupli-
cations, deficiencies, or rearrangements of the 
chromosome material. Even the smallest duplication 
or deletion recognizable by current technology can 
result in major phenotypic abnormalities. For ex-
ample, Figure 6 shows an array of pairs of chromo-
some 4 ascertained in a child referred to MCV be-
cause of severe multiple congenital anomalies noted 
at birth. Briefly, this infant female had microcephaly 
with a midline occipital scalp defect, mild hypotelor-
ism, low-set, simple ears with preauricular pits, bilat-
eral cleft lip and palate, and a bulbous nasal root. She 
also had mild flexion deformities of both thumbs and 
hypoplastic nails, as well as congenital heart disease 
and a shallow pilonidal dimple. Cytogenetic evalua-
tion revealed a modal number of 46 chromosomes, 
but as this figure demonstrates, one of the chromo-
somes 4 consistently showed a lesser amount of short 
arm material than the homolog, and banding analysis 
revealed a terminal deletion in the short arm: 
46,XXdel(4)(pl5 or pl6). 
Unfortunately, in the above case, the cytogenetic 
diagnosis was made postnatally. Further refinements 
of our current technology will soon permit such mi-
nor chromosome anomalies to be detected prenatally, 
and as more patients elect antenatal genetic testing 
and as banding and optical technology are improved, 
karyotype analysis of the fetus will become an even 
more precise diagnostic tool. 
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IV. CLINICAL PROGRAM 
The Genetic Counseling Program at MCV 
PHYLLIS WINTER, Clinic Coordinator, Department of Human Genetics 
PETER MAM UN ES, M .D ., Professor of Pediatrics and of Human Genetics 
WALTER E. NANCE, M.D., PH.D., Professor of Human Genetics, Pediatrics, and Medicine 
The Genetic Counseling Clinic at the Medical 
College of Virginia, established by Ors. Peter Ma-
munes and R. B. Young in 1973, has been supported 
since its inception by a clinical service grant from the 
National Foundation-March of Dimes; it is one of 
83 genetic counseling programs in the United States 
and one of three in Virginia that receive support from 
the Foundation. The Clinic provides counseling and 
diagnostic services for a variety of genetic diseases 
and is the focus of clinical teaching and research 
activities of the Department of Hum an Genetics . The 
Clinic is staffed by members of the Departments of 
Human Genetics, Obstetrics, and Pediatrics , as well 
as consultants from many other clinical disciplines . 
Following referrals, patients are sent a question-
naire to initiate the collection of relevant medical and 
genetic data; the patient is then scheduled for a Clinic 
appointment. At the time of the Clinic visit, the grad-
uate student interviews the patient and documents 
sufficient family history information to permit the 
construction of a pedigree. Following review of the 
collected data and physical examination of the pa-
tient by the staff physician , the patient and family are 
invited to continue the counseling session in a room 
equipped with a microphone and a two-way mirror. 
In this setting, students, house officers, and staff 
members can participate in the counseling session in 
an unobtrusive manner, and discuss it later. About 
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90% of the patients and families are willing to partici-
pate in this educational program; those who object 
are counseled privately . 
After a year's experience in the Genetic Counsel-
ing Clinic, graduate assistants are assigned to spe-
cialty areas such as hemophilia, cystic fibrosis, and 
endocrine clinics, where they collect family history 
data in selected cases , under the supervision of the 
Clinic director and augment the genetic counseling 
the families have previously received. Although vir-
tually all patients seen by the graduate assistant in 
these clinics have a clearly defined Mendelian disease, 
many may not have received adequate genetic coun-
seling in the past. 
Since its beginning in 1973, the Clinical Genetics 
Program has evaluated or counseled 698 individuals 
(Table); of these, 33.7% were diagnosed as having 
a simple inherited Mendelian trait and 45 .6% a 
recognizable chromosomal disorder. Twenty-one 
dominantly inherited traits were diagnosed includ-
ing achondroplasia, neurofibromatosis, Huntington 
chorea, Marfan syndrome, retinitis pigmentosa, hy-
pochondroplasia, Noonan syndrome, aniridia, limb-
girdle dystrophy, Treacher-Collins syndrome, and 
tuberous sclerosis; 28 recessive traits were diag-
nosed including cystic fibrosis , alpha-1-antitrypsin 
deficiency, recessive deafness, Tay-Sachs disease, 
Werdnig-Hoffman disease, galactosemia, phenyl-
ketonuria, Gaucher disease, Usher syndrome, and 
maple syrup urine disease. X-linked traits seen in the 
clinic included Duchenne muscular dystrophy, hemo-
philia, Norrie disease, anophthalmia and Charcot-
Marie-Tooth disease. Most of the cases seen with 
chromosome anomalies had Down syndrome, but the 
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Summary of Genetic Clinic Population: 1973-1977 
Year Tota l 
1977 Num- Percent 
C lassification 1973-75 1976 Jan-June ber of total 
Dominant 
traits 16 55 40 111 12.2 
Recessive 
traits 46 54 61 161 17.8 
Sex-linked 
traits 16 II 7 34 3.7 
Chromosomal 
disorders 106 258 49 413 45.6 
Multi factorial 
traits 16 24 10 50 5.5 
Other 
conditions 41 55 42 138 15.2 
TOTAL 241 457 209 907 100.0 
sample included patients with D and E trisomy, the 
cri du chat syndrome, Turner syndrome, Klinefelter 
syndrome, the 4p-syndrome, and a variety of struc-
tural rearrangements. 
Patie.nts classified as having multifactorial dis-
eases included individuals with midline neurologic 
defects, diabetes, uncomplicated cleft lips and/ or pal-
ate, clubfeet, seizures, and certain patients with famil-
ial mental retardation that could not be otherwise 
classified. Patients falling into the other categories 
included individuals with multiple malformations or 
repeated abortions with normal chromosomes and no 
other definite causes, or patients with psychomotor 
retardation of unknown or environmental etiology. 
During the year 1976 (Figure), patients came 
from all parts of the state either to the Genetic Coun-
seling and Amniocentesis Clinics or for diagnostic 
karyotypic analysis. This pattern of referrals is 
largely a result of the central location of the Clinic in 
a large urban area. 
Referrals to Genettc Coooseing Program 
from Virginia's Health C•e Districts, 1976 
Figure-Pattern of referrals to Genetic Counseling Program 
from Virginia's health care district, 1976. 
Population Screening for Genetic Disease 
PETER MAMUNES, M .D., Professor of Pediatrics and of Human Genetics 
Recent advances in genetics and laboratory tech-
niques have raised difficult issues for both the medical 
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and lay communities. The desirability of initiating 
population screening progr.ams is an example of one 
such issue that has engendered considerable con-
fusion concerning its intent-so much so that the 
National Academy of Sciences recently reviewed this 
subject and in 1975 published a book entitled, Ge-
netic Screening-Programs, Principles and Research. 1 
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This presentation will describe the four major forms 
of population screening for genetic disease and, from 
the Virginia experience with some of them, demon-
strate their strengths and shortcomings. 
Most readers are already aware of programs to 
screen for disorders such as hypertension, diabetes, 
cervical cancer, glaucoma, and other diseases. These 
programs were established with the idea that they are 
inexpensive, can be detected by a simple test, and that 
effective treatment is available. The same principles 
apply to the four major types of population screening 
programs for genetic disorders. 
I. Carrier detection. Almost all persons are be-
lieved to carry approximately four lethal or dele-
terious recessive genes; however, their existence is 
usually never known unless the spouse has the same 
gene, in which case there is a one-in-four chance that 
each child will inherit a "double dose" of the abnor-
mal gene and develop the disorder. Fortunately, most 
serious recessive diseases are rare, but there are two-
sickle cell disease and Tay-Sachs disease-which are 
especially prevalent in specific subpopulations and 
for which simple, reliable, and relatively inexpensive 
carrier tests are available. Screening programs for 
detection of heterozygotes (carriers) in both disorders 
have existed in Virginia for at least five years. Else-
where in this issue experience with the Medical Col-
lege of Virginia Sickle Cell Program is described. 
Tay-Sachs disease affects approximately 1 : 4,000 
Ashkenazi Jewish births and is invariably lethal by 
the fourth year because of the abnormal accumula-
tion of a sphingolipid, ganglioside G M 2 , in the cen-
tral nervous system.2 Hexosaminidase A, the enzyme 
which is necessary for the normal degradation of this 
material, is inactive in these patients and is present in 
only approximately 50% of normal activity in the 
serum, white blood cells, and other tissues of carriers. 
Women who are at risk to give birth to such children 
can therefore be identified before pregnancy. If both 
parents are carriers, an amniocentesis performed in 
the second trimester can determine the enzyme status 
of the fetus. If Tay-Sachs disease is found, the parents 
then have the option to terminate the pregnancy to 
avert the birth of an affected child. 
Measurement of the serum enzyme level is not in 
itself technically difficult, but so many factors affect 
its activity (for example, pregnancy, cleanliness of 
test tubes in which blood is collected, the time during 
which the serum remains at room temperature before 
freezing, storage temperature prior to testing, medi-
cations taken by patient) that it is not practical for 
the local physician to forward blood to the testing 
laboratory from patients wishing their carrier status 
determined. Although with special precautions and 
arrangements, testing of remote patients can be done, 
a more desirable procedure is to schedule periodic 
mass community testing at various sites. These mo-
bile screening clinics not only obviate the above-
mentioned difficulties but they offer a better opportu-
nity to ensure that tested individuals have been prop-
erly informed regarding the purpose and possible 
consequence of the testing. Because this concept of 
carrier testing is a new one, the most difficult aspect 
of such screening is to educate the public in the 
importance of voluntary participation. Most people 
will not have heard of the disease, and what is more 
significant they find it difficult to believe that they 
have a I: 30 chance of being carriers. A second ob-
stacle to successful screening is the lack of funding for 
such programs. After initial equipment cost outlay, 
the cost for the Tay-Sachs test averages $7 .00 ± 
$2.00, depending on the volume of tests, per individ-
ual. The MCV Tay-Sachs Screening Program, oper-
ative since 1972, was fortunate to obtain initial sup-
port from the Virginia State Department of Health 
and local Jewish community organizations so that it 
has been able to offer the test without a fixed charge 
to tested persons. 
As a result of Virginia screening, over 3,700 Jew-
ish persons have been tested at sites in their own cities 
of Richmond, Norfolk, Newport News, Roanoke, 
and Fredericksburg; the metropolitan northern Vir-
ginia cities have used testing sites in southern Mary-
land and Washington, D.C., provided by Johns Hop-
kins Hospital. Over 100 carriers have been identified 
and counseled, but surprisingly no carrier couple has 
thus far been found. A full 25% of all adult Jewish 
people in these cities have been tested. In almost all of 
the more populous United States cities where testing 
has been offered for several years, no more than 5% 
to I 0% have appeared for this voluntary test. Clearly, 
a significant educational effort is needed on two 
fronts: to convince governmental agencies of the need 
for appropriate funding for these programs and to 
inform the public regarding the concept of disease 
prevention by carrier detection. Support of these ef-
forts is needed soon, for in the very near future car-
rier detection tests for other more common recessive 
diseases, such as cystic fibrosis, promise to be avail-
able. 
Phenylketonuria (PK U) carrier detection is a 
second test that we currently provide, using a dis-
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criminant function, based on serum amino acid lev-
els, that we have recently developed in our labora-
tory. In this case, since there is no ethnic group in 
which the gene has a high incidence, we offer the test 
to the collateral relatives of all new cases of PK U that 
come to our attention. 
2. Antenatal screening. There is a ~mall but 
clearly definable group of pregnant women , for whom 
screening is indicated because of their substantially 
increased risk of bearing a child with a genetic dis-
order. The Antenatal Testing Program, jointly ad-
ministered by\ the Departments of Obstetrics and Gy-
necology, Human Genetics , and Pediatrics, is 
discussed elsewhere in this issue. 
3. Mass neonatal screening. The prototype in 
this level of screening is the Guthrie test to detect 
PK U, an assay performed on a dried blood spot 
obtained in the first week of life. Virginia State law 
established the program in 1966 and made it the joint 
responsibility of the parent and/ or the physician to 
provide that the neonate be screened for this condi-
tion. Since that time, four to five children with PK U 
per year (approximately 1: 16,000 births) have been 
discovered and mental retardation averted by main-
taining them on a phenylalanine-restricted diet for 
the first six to seven years of life. The cost for early 
screening and treatment is approximately one tenth 
the cost of special education or institutionalization of 
late-diagnosed, retarded PK U children . 
With the demonstrated success of the PK U 
screening program , many states and foreign countries 
have established screening programs for other dis-
orders using the same blood spots. The grafting of 
these additional programs onto an already-existing 
one and the availability of a machine to handle the 
blood-spotted filter paper have minimized their cost. 
The decision of which additional disorders to screen 
should relate to the following major factors: 
a) frequencyofthedisorder, 
b) severity of the untreated disorder, 
c) simplicity and sensitivity of the test, and 
d) availability of treatment to ameliorate or pre-
vent the disorder. 
Under the above considerations, hypothyroidism (by 
radioimmunoassay of thyroxine), galactosemia (by 
bacterial inhibition assay) , and several amino-
acidopathies including homocystinuria, maple syrup 
urine disease (MSUD), and histidinemia (all also by 
bacterial inhibition assay) qualify .3 Because of its 
frequency ( 1 : 6,000) and ease of treatment, and the 
severity of the mental retardation that ensues due to 
delayed diagnosis, hypothyroidism warrants immedi-
ate development of screening programs .4•5 Therefore, 
a neonatal hypothyroid screening program in Vir-
ginia is planned for 1978. It is hoped that additional 
programs for galactosemia and other aminoacido-
pathies will also be initiated soon. 
The spectrum of metabolic disorders screened 
can be considerably expanded if the urine of two- to 
three-week old infants is .aiso tested by various simple 
chromatographic and high-voltage electrophoretic 
techniques . Such a program, using specimens col-
lected on filter paper at home by the parent and 
mailed to the central laboratory performing the 
blood tests, has already been in effect for several 
years in M assachusetts6 and several other states. This 
procedure also serves as a follow-up test to detect 
neonates with false-negative blood results for the 
previously mentioned aminoacidopathies, including 
PKU. 
Except for the PKU program, testing for other 
disorders in Virginia and most other states is and will 
be voluntary. An advisory committee of consumers, 
experts in metabolic disease, geneticists, laboratory 
personnel , clergy, and ethicists is clearly needed to 
serve as an advisory body to determine the propriety 
and mode of administration of these proliferating 
programs. 
4. Urine metabolic screening. While the total in-
cidence of ihborn errors of metabolism is probably 
no greater than 1: 5,000, these disorders are more 
often seen in children with mental retardation, sei-
zures, hepatosplenomegaly, recurrent or persistent 
acidosis, failure to thrive, or unusual odor to urine or 
sweat. Where the etiology of any of these conditions 
is unclear, one of the inborn errors of metabolism 
must be considered; therefore, a variety of simple 
tests on a random urine specimen is recommended to 
screen for over 30 such disorders of amino acid, 
mucopolysaccharide, and carbohydrate metabolism.7 
At the pediatric metabolic laboratory the following 
tests are routinely performed weekly on a 20 ml acid-
ified random urine specimen received by mail: a) 
ferric chloride and dinitrophenylhydrazine tests to 
detect the alpha-keto acid excesses found in PKU, 
tyrosinemia, MSUD, and histidinemia; b) silver ni-
troprusside test for homocystinuria; c) Benedict's 
tablet for reducing substances; d) gross turbidity test 
for mucopolysaccharidoses; e) isatin spot test for the 
iminoaciduria of praline or hydroxyproline excess; f) 
nitrosonaphthol test for tyrosinosis; and g) high-volt-
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age separation of all urinary amino acids to detect 
any excesses. Although the yield of newly diagnosed 
inborn errors by this screening program is small, 
those few cases detect~d are important because they 
may le;:id to a specific diagnosis that permits a prog-
nosis, a recurrence risk for other family members, 
and counseling about the possibility of treatment or 
prenatal diagnosis for future pregnancies. 
Clearly, genetic screening programs are an im-
portant component of the primary care physician's 
efforts in preventive medicine. Participation in and 
support of these programs is therefore strongly 
urged. 
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The Virginia Sickle Cell Anemia Awareness 
Program (VaSCAP): Education, Screening, 
and Counseling 
FLORENCE N. COOPER AND ROBERT B. SCOTT, M.D., Department of Medicine 
In 1968, a program of screening for sickle trait 
carriers was begun as part of the work of the Hema-
tology Division, Department of j'vtedicine, at the 
Medical College of Virginia. It was felt that sickle cell 
Correspondence and reprint requests to Robert B. Scott, 
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anemia was more of a public health problem than 
was generally recognized, and in addition to institut-
ipg screening and education programs, data were col-
lected to document the relative neglect of the prob-
lem. 
A survey of the Cjty of Richmond was con-
ducted to ascertain the level of awareness among 
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black adults of sickle cell anemia, a severe chronic 
disease affecting one of every 500 black babies. The 
results' showed that only 3 of every I 0 black adults 
had ever heard of this disease, and of those who 
recognized it, few understood the nature of the ill-
ness. Additional background information was col-
lected which further showed the lack of professional 
and public understanding of the importance of sickle 
cell anemia as a public health problem. These data,2 •3 
which attracted widespread attention, showed that 
sickle cell anemia research received far less support 
than other much Jess common chronic illnesses. 
Public attention was also focused on sickle cell 
anemia by publicity concerning a new "test tube" test 
for sickling, and claims for therapeutic benefit from 
intravenous urea solutions. The heightened interest in 
sickle cell disease finally resulted in the Sickle Cell 
Anemia Prevention Act of 1972, which included a 
series of sickle cell research and treatment centers 
plus screening, education , and counseling clinics 
throughout the nation. At that time VaSCAP com-
peted successfully for a contract under the national 
program, and expanded from a small screening effort 
to a larger, well-staffed clinic which could extend its 
effects state-wide. 
Although the ability to detect healthy carriers of 
the recessive sickle trait had existed for years, no 
widespread screening and genetic counseling had 
taken place prior to these new programs. Another 
factor which made mass screening economically fea-
sible was the development of rapid, simple in-
struments for performing hemoglobin elec-
trophoresis. Electrophoresis has distinct advantages 
over the classical sickle cell "prep" or the .newer test 
tube tests since it can distinguish sickle trait from the 
homozygous state, sickle cell anemia, and can also 
detect numerous other hemoglobin variants . 
The purpose of screening for abnormal hemo-
globins is to give young people an opportunity, not 
previously available, to know in advance of child-
bearing whether they run the risk of having children 
with sickle cell anemia. The frequency of sickle tr:tit is 
about 8% of the black population, or I in every 12 
blacks. The chance, then, that both potential parents 
in a couple are trait carriers is I in 144; thus slightly 
less than I% of black couples a re composed of two 
trait carriers and are at risk for bearing children with 
sickle cell anemia. The chance is 1 in 4 with each 
pregnancy that a child will be born with this incurable 
illness. 
Screening should not be performed without ade-
quate prior education. To implement this principle, 
VaSCAP has developed a number of audiovisual 
programs and written materials suitable for a wide 
variety of audiences. Included in these are the Sickle 
Cell Anemia Fact Book,4 a booklet for teachers, 
nurses, and other professionals, and Our Sickle Cell 
Story Fact Book,5 for elementary and middle school 
students. These, as well as brochures, posters, and 
fact sheets are distributed through the Virginia State 
Department of Health, to many areas of Virginia and 
throughout the nation. Since its inception, VaSCAP 
has provided educational sessions to over 200,000 
individuals in groups of various sizes. It has also 
reached many more through programs, spot an-
nouncements, and structured educational models for 
specific target groups with the result that screening 
for hemoglobin genes has become an acceptable pro-
cedure among the general population. At present 
over 42,000 persons have been screened by hemoglo-
bin electrophoresis and 3,951 have been found to 
have hemoglobin variants. 
The ultimate result of education and screening is 
counseling those found to have sickle or other mutant 
hemoglobin genes. Counseling is aimed at educating 
the individual so that he or she can know the nature 
of the sickle gene, understand what sickle cell anemia 
is, understand the probabilities of transmitting the 
genes, and then be able to make informed decisions 
about childbearing.There is a set of slides available 
which has been developed by the VaSCAP staff. 
These explain the probabilities of inheritance for each 
specific hemoglobin variant. Individuals newly diag-
nosed with sickle cell anemia or one of its variants 
have been referred to a family physician or to the 
Hematology Clinic at MCV. 
Approximately 8% of Virginia blacks have been 
found to have sickle cell trait, and 2% carry hemoglo-
bin C trait. About 0.3% have the gene for hereditary 
persistence of feta l hemoglobin (HPFH), which is a 
gene mutation not associated with any disease. In 
addition , a large number of less common mutant 
hemoglobin genes have been recognized. 
Though the alkaline electrophoresis test is the 
primary method used for the detection of hemoglobin 
genes, there are other methods which may be re-
quired in order to provide more conclusive results. 
The laboratory of the VaSCAP clinic provides both 
alkaline and acid or citrate agar electrophoresis. A2 
mini-columns for hemoglobin A2 quantitations are 
very useful in detecting the Beta thalassemias; fetal 
hemoglobin staining aids in determining the presence 
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of HPFH. Family studies are necessary in certain 
cases and the clinic has screened as many as four 
generations in some families. 
All of the services have been provided without 
charge to the public or physicians for whom diagnos-
tic testing has been performed. The emphasis has 
been on testing persons in or approaching the child-
bearing age. 
Education programs have been carried out in 
most high schools and colleges in central Virginia and 
the Tidewater area . Church groups and community 
organizations regularly request programs, many of 
which are provided in evenings or on weekends. An 
important part of the educational effort has been to 
provide workshops to train public health nurses in 
genetic counseling relating to hemoglobinopathies. 
State legislstion has provided funds for nurses to be 
designated as genetic counselors in all of the Health 
Department clinics in the State. VaSCAP has also 
worked closely with local health departments in pro-
viding consultations concerning diagnosis and coun-
seling of individuals with unusual hemoglobin vari-
ants . 
The number of individuals served by the VaS-
CAP clinic is a tangible measure of its performance, 
but it does not reflect all of the benefits to the public 
and health professionals. The tragic lack of public 
awareness of the importance of sickle cell anemia that 
characterized the beginnings of this program has dis-
appeared. For health professionals, especially at 
MCV, the subject of hemoglobinopathies has been 
emphasized repeatedly, and the level of interest and 
understanding of the disease and its variants have 
risen considerably. Of particular significance are the 
improved diagnostic facilities provided by VaSCAP 
clinics which have made it possible to stress the more 
rigorous modern standard of diagnosis for hemoglo-
bin disorders. 6 Perhaps most important to the field of 
genetics generally has been the extensive practical 
experience gained by the first mass screening efforts 
for a heritable disease. The ease with which recessive 
hemoglobin genes are detected made it the first such 
program to be implemented; as additional gene tests 
are developed, other genetic diseases will be the tar-
gets of similar programs. 
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Genetics and Cancer 
JOHN M. MUELLER, M.D. AND ROBERT B. DIASIO, M.D., Division of Medical Oncology 
The existence of a relationship between cancer 
and heredity has been recognized for years, but only 
recently has emerging knowledge in this area enabled 
physicians to detect and treat cancer earlier in af-
fected individuals and to prevent its occurrence in 
others. 
The genetics of human cancer can be divided 
into three categories: first, cancers inherited by direct 
gene transmission; second, familial disorders not 
characterized by malignant disease themselves but 
which predispose to an increased likelihood of devel-
oping cancer; third , cancers of one or more types 
occurring with an increased incidence within a family 
but with a mode of genetic transmission that may not 
be clear. 
A relatively small proportion of cancers are in-
herited as a result of direct single gene transmission . 
One example is retinoblastoma, a highly malignant 
tumor of the eye which presents in early childhood, 
and which occurs in two different forms. The less 
common familial form of the disease is usually trans-
mitted as a highly penetrant dominant trait, with af-
fected individuals often having bilateral involvement 
and a somewhat earlier age of onset. The more com-
mon form is characteristically sporadic, with affected 
individuals having unilateral disease and a later age 
of onset. 1 As more affected persons will now reach 
adulthood and reproduce because of improved treat-
ment, clarification of the mode of inheritance is 
mandatory to allow proper genetic counseling. 
Multiple endocrine adenomatosis type II or 
Sipple syndrome consists of the association of medul-
lary carcinoma of the thyroid, pheochromocytoma, 
and parathyroid hyperplasia . This disorder appears 
to be inherited as an autosomal dominant but with 
incomplete penetrance. As with many inherited can-
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cers, there is an increased incidence of bilateral organ 
involvement. Clinically, the patient may present with 
evidence of carcinoma in only one system; for ex-
ample, medullary carcinoma of the thyroid may be 
present without a palpable thyroid nodule. However, 
appropriate testing may show occult disease in the 
other organs. An elevated serum calcitonin level may 
suggest an occult cancer in predisposed individuals2; 
therefore, diagnosis of any of the features of this 
unusual syndrome should lead to careful exclusion of 
the others, as well as to a search among close relatives 
for additional, possibly presymptomatic, cases. 
Familial polyposis coli is an autosomal domi-
nant disorder in which adenomatous polyps may be 
so numerous that they actually carpet the entire colon 
and rectum; Gardner syndrome is a distinct variant 
that includes associated sebaceous cysts and osteo-
mas of bone. Early recognition of these disorders is 
critical since virtually I 00% of affected persons will 
develop carcinoma of the colon by age 50 unless a 
prophylactic colectomy is performed.3 A number of 
oncologists now recommend total colectomy as soon 
as the disorder is discovered in childhood unless it is 
possible to follow the affected child with regular sig-
moidoscopies and barium enemas. The management 
of these families can be extremely difficult since it is 
essential both to stress the importance of regular 
examination and to avoid contributing to an obses-
sive cancer phobia. 
Neurofibromatosis is an a utosomal dominant 
disorder characterized by cafe au lait spots and mul-
tiple neurofibromas. The neurofibromas show a sar-
comatous degeneration in about 10% of patients, and 
there is an increased risk of gliomas of the brain or 
optic nerve, meningiomas, acoustic neuromas, and 
pheochromocytomas. 
Xeroderma pigmentosa is a rare disorder mani-
fested by sun sensitivity and the development of 
freckles on sun-exposed areas which then become dry 
and scaly. Basal cell and squamous cell carcinomas of 
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the skin later develop , and even if they are arrested , 
affected individuals have an increased risk of mela- Neoplasms with Possible Familial Occurrence 
noma .1 Xeroderma pigmentosa is transmitted as an 
autosomal recessive trait. The defect has been shown 
to be a specific deficiency in one of the several en-
zymes normally required to repair ultraviolet radia-
tion damage to the DNA of epidermal cells .4 When 
the precipitating causes of the problem are appreci-
ated, the physician can teach affected individuals to 
protect themselves from the carcinogenic effects of 
ultraviolet radiation without undue disruption of a 
normal lifestyle.5 
Immune deficiency disorders are associated with 
an increased incidence of cancer, particularly lym-
phoma. The prime examples are the recessively inher-
ited syndromes such as X-linked agammaglobuli-
nemia, ataxia tel angiectasia, and Wiskott-Aldrich 
syndrome. Individually, each of these recessive syn-
dromes is rare, and in the aggregate, affected homo-
zygotes (or hemizygotes if the trait is X-linked) con-
stitute only a small proportion of all patients who 
develop cancer. However, there is increasing evidence 
that heterozygous carriers of at least some of these 
recessive genes may also be predisposed to cancer. 
Carriers of rare recessive genes are, of course, much 
more numerous in the general population than are 
affected homozygotes; in fact , the rarer the recessive 
trait, the greater the relative frequency of hetero-
zygous carriers in the population in comparison with 
affected homozygotes . Therefore, a small effect of 
cancer risk in heterozygotes could have much greater 
public health significance than would a major effect 
in homozygotes. Swift6 has provided convincing evi-
dence that heterozygous carriers of the genes for 
ataxia telangiectasia and Fanconi anemia have a 
three- to fourfold increased risk of developing cancer; 
he has estimated that at least 3% of all cancers arise in 
individuals who are heterozygous for one or the other 
of these two genes alone. At present, no laboratory 
test is available to identify carriers . 
Detecting an increased familial risk of cancer 
and following the involved family members for evi-
dence of developing neoplasia is an important activ-
ity for practicing physicians. The cancers may be 
always of the same organ , that is, a site-specific tumor 
may occur in familial aggregations, or they may be of 
multiple varied organs. The Table lists the site-spe-
cific malignant neoplasms with possible familial oc-
currence.7 
There is considerable heterogeneity in the ge-
netics of certain cancers, especially breast cancer. 
Breast 
Colon 
Stomach 
Prosta te 
Endometrium 
Hodgkin di sease 
Walden strom disease 
Multiple myeloma 
Leukemia 
Lymphoma 
Hepatocellular tumors 
Testicular tumors 
Neuroblastoma 
Wilms tumor 
Burkitt lymphoma 
Bronchogenic carcinoma 
Ovari a n ca rcinoma 
Studies8 - 10 have helped elucidate some of the risk 
factors . It is important to know whether the disease 
has occurred in two or more female first-degree re-
latives, whether the disease was pre- or post-meno-
pausal in onset, and whether it was bilateral. In 
the premenopausal age group, the relative risk of 
breast cancer among family members of an affected 
individual is approximately three times that of con-
trols, whereas in the postmenopausal age group, the 
risk is only slightly greater than that of controls. 
Relatives of women with bilateral disease have a five-
fold risk compared to controls. The relatives of 
women with premenopausal and bilateral disease 
have a relative risk of developing breast cancer that is 
almost nine times greater than that of controls, while 
the relatives of patients with postmenopausal bilat-
eral disease have a risk that is four times greater. The 
risk to other family members also depends upon the 
relationship of prior affected persons to the proband . 
For example, if prior disease involved a proband's 
mother, the proband's sisters will have a 30% in-
cidence of cancer in the 20-to 29-year age group, a 
risk 47 times greater than that of the general popu-
lation . Clearly, these facts imply a genetic factor in 
breast cancer which appears most consistent with 
polygenic inheritance of a predisposition . Physician 
recognition of and response to this inherited pre-
disposition is important particularly in the high-risk 
situation. In one such family , for example, bilateral 
reduction mammoplasty with implantation of a sub-
cutaneous prosthesis was recommended for a 19-
year-old girl whose two sisters, mother, and maternal 
grandmother had had early onset of breast cancer. 11 
The concept of "cancer families" has been 
broadened to include kindreds displaying familial oc-
currence of diverse neoplasms even of dissimilar cell 
types. 12 The cancer family has the following charac-
teristics: I) an increased occurrence of adenocarci-
noma primarily of colon and endometrium; 2) in-
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creased frequency of multiple primary malignant 
neoplasms; 3) early age of onset of cancer relative to 
the usual age of onset of that cancer in the general 
population; 4) vertical transmission of cancer consis-
tent with an autosomal dominant inheritance pattern. 
One such family has been described in Virginia. 13 
Environmental factors may also influence ex-
pression of the disease when there is a familial ten-
dency to cancer. Studies by Tokuhata have confirmed 
an increased incidence of cancer of the lung in rela-
tives of patients with lung cancer, and his data sug-
gest that the combined risk of cigarette smoking and 
the familial host factor increase the liability of devel-
oping lung cancer in a synergistic rather than additive 
manner. 1• 
The interrelationships between heredity and en-
vironment in the occurrence of cancer are complex 
and in many cases not completely characterized, but 
certain facts are clear. Specific cancers can be inher-
ited directly . Certain diseases that predispose to can-
cer are inherited, and specific cancers or specific ten-
dencies to develop a variety of cancers are inherited 
in families. Examples of each of these have been 
discussed. The long-range challenge to physicians is 
to recognize these situations and to study them thor-
oughly to further our understanding of the causes of 
cancer. More immediately, however, the alert physi-
cian who takes a detailed family history can recognize 
the increased risk of a particular malignancy and, by 
careful examination, testing, advice, and follow-up, 
can provide early treatment or even prevent the de-
velopment of a potentially fatal malignancy. 11 
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The Genetic and Somatic Effects of 
Radiation: A Balance Between Benefits and 
Risks 
TIMOTHY MERZ, PH.D., Professor and Chairman, Division of Radiation Biology, and Professor, Department 
of Human Genetics 
The present clinical interest in mutagenic agents 
in general and radiation in particular can be seen in 
the current proliferation of popular articles and re-
ports on the effect of mutagens and radiation on 
biological systems. In spite of the continuing con-
troversy over the effects of radiation from environ-
mental sources, the most significant problem today is 
the increasing x-ray exposure of individuals due to 
increasing radiological diagnostic capability and the 
expanding importance of radiographic procedures in 
medical diagnosis . 
Although man has survived radiation from natu-
ral sources during the course of his evolution, there is 
a point at which the risk of exposure is greater than 
any benefit that might be derived. The exposure dose 
at which that risk occurs and how it is influenced by 
the rate of exposure are being studied here at the 
Medical College of Virginia and many other institu-
tions. The human system is extraordinarily well 
adapted to respond to the effects of radiation, chem-
ical mutagens, and clastogens (compounds that break 
DNA strands and chromosomes) through a repair 
mechanism which more often than not returns things 
to normal, but there is a limit to its capacity. 
The genetic risk of radiation has been recognized 
since 1927 when Muller reported that radiation in-
duced mutations in fruit flies. 1 Auerbach, using nitro-
gen mustard during World War II, demonstrated that 
chemicals could produce the same kinds of effects as 
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radiation.2 We are now becoming aware of the mag-
nitude of the threat that chemical mutagens pose for 
us in our environment. Since most chemical muta-
gens and clastogens produce effects similar to those 
of radiation, have the same targets and a similar 
dependence on dose and rate of exposure, and since 
the consequences are much the same although the 
mechanisms are quite different, I will concentrate 
almost entirely on the effects of radiation . 
Radiation does not cause new kinds of genetic 
alterations but an increase in the frequency of altera-
tions above the spontaneous level. Also there is no 
obvious threshold dose of radiation; that is, there is 
no dose below which there is no effect. Although no 
threshold dose of radiation exposure has ever been 
established, it is probably true that very low doses 
impose a very low order of risk. 
Human damage by radiation is divided into two 
groups-germ cell (or presumptive germ cell) damage 
and somatic cell damage. The primary events of alter-
ation, be it the genome, induction of cancer, or death, 
are always intracellular, the target being the genetic 
material found in the nucleus and organized as 
chromosomes. Thus, whatever the nature and extent 
of damage done to humans, it is always first ex-
pressed by cells, then by tissues or organs, and finally 
by the individual. The repair of altered DNA is ac-
complished by a group of enzymes that work with 
great speed and accuracy. Most of the damage pro-
duced by a dose of radiation is repaired by the cell in 
a very short time, but repair systems do not repair all 
of the damage nor is all repair perfect. Many cells 
will, for several reasons, survive and retain their func-
tion in the face of sustained genetic alterations. First, 
cells maintain their synthetic function after exposure 
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to doses of radiation that would kill human beings. 
Enzyme systems and systems that synthesize protein 
in general are not sensitive to large doses of radiation. 
Second, the loss of genetic material is not necessarily 
significant tp cells that have differentiated and use 
only that information from the DNA that is pertinent 
to their particular task. Third, the loss of genetic 
material is most often the loss of one half of that 
w.hich is supplied to the cells since it gets informa-
tional content from both parents. Fourth, some of 
the 'genetic material is redundant and the loss of part 
of it, while it may result in reduced capability, will 
not necessarily result in death. Although cells can 
function after exposure to radiation, a large number 
of them will lose their ability to divide and replace old 
cells. After doses of radiation of approximately 200 
rads, many cells loose their reproductive integrity. 
That loss is defined as reproductive death. Death , 
reproductive or actual, is only one significant result 
of radiation . Changes in DNA base pairs, deletions 
of materials, or chromosomal alterations often result 
in mutations that are usually recessive and almo~t 
always deleterious. When expressed, they result in the 
loss of enzyme function and altered proteins. There is 
a growing list of known enzyme-deficient disorders 
and of stn.ictural protein abnormalities, sucb as ab-
normal hemoglobin variance, in man. Recessive mu-
tations are not observed until they are present in both 
maternal and paternal chromosomes and therefore 
take at least two generations of breeding to be ex-
pressecj. In somatic cells recessive mutations will of-
ten go unnoticed; large losses or rearrangement of 
material seen as chromosomal changes, chromosome 
and cpromatid aberrations, exchanges of material be-
tween chromosomes, and large losses of pieces of 
chromosomes usually cause more trouble and often 
result in the death of the cell. In addition to causing 
changes in the structural integrity of chromosomes, 
radiation often results in changes of chromosome 
number either by the addition or deletion of whole 
chromosomes. Radiation-induced genetic damage 
can be yxpressed in many ways, the simplest of which 
go unnoticed. While death may be the most severe 
result of a mutation, cell death is a minimal problem 
for an organism whose tissues renew cell populations 
continually; however, the death of many cells in criti-
cal stem cell populations of renewal tissues such as 
the gut or the marrow will cause the death 'of the 
individual. But these events do not occur as the result 
of incidental exposure to: radiation. 
The effects of low doses of radiation, chemical 
' ' 
mutagens or clastogenic agents can be listed for both 
germ cells and somatic cells. The expressions of dam-
age to germ cells are abortions, stillbirths, and con-
genital defects including all the known trisomies such 
as Down syndrome. The fact that radiation can in-
duce trisomic developmental anomalies in early 
cleavage cells and germ cells is based both on theoret-
ical considerations and on observations from pub-
lished studies. The failure of chromosomes to disjoin 
at mitosis or meiosis is a well known result of ex-
posure to radiation and an event preliminary to the 
production of trisomics. Germ cells or early cleavage 
stage cells (em bryogenesis) that are missing chromo-
somes due to nondisjunction or have extra chromo-
somes for the same reason usually fare poorly and 
often result in fetal death. The best studies oftrisomic 
or polysomic conditions in man are those involving 
the sex ~hromosomes . Extra sex chromosomes and 
missing sex chromosomes often produce less dele-
terious consequences in fetal development than 
changes in number of other chromosomes, but tbey 
are never without later developmental cc:msequences. 
The same developmental problems can be produced 
by the insertion of pieces of chromosomes in other 
chromospmes or the loss of pieces of chromosomes. 
The e1(pression of somatic cell damage depends 
on when the damage is d~ne . Damage done to fetal 
cells wi)I often result in congenital defects and/ or 
death. A minimal number of cells altered a't the time 
when they are differentiating into a tissue or organ 
system can produce a partially or totally defective 
system . The earlier in development that exposure to 
radiation occurs, the greater is the risk of congenital 
defects. The risk of a particular system being defec-
tive is dependent on the stage of differentiation of 
that system at the time of radiation exposure. Differ-
entiating cells are by far the most sensitive cells in the 
human system and they are apparently sensitive be-
cause their repair systems are not operating during 
the time they are differentiating. Differentiating cells 
are sixtyfold as sensitive as nondifferentiating cells . 
It is also clear that cells undergoing the complex 
process associated with organogenesis are particu-
larly susceptible to genetic loss. Following organ-
ogenesis , the systems become considerably more re-
sistant to radiation exposure or exposure to chemical 
mutagens. The first two trimesters of fetal develop-
ment have been considered by radiologists to be so 
sensitive that most try to avoitj extensive radiological 
investigations to women who may be pregnant. The 
last trimester has been considered to be a safe period 
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to the fetus, but current investigators have raised 
some questions about the extent of fetal resistance io 
radiation-induced damage even at that period of fetal 
development. Probably the most extensive investiga-
tion of the effect of radiation on developing fetuses is 
the Oxford Study directed by Stewart et al,3 which for 
all its excellence remains one of the most informative 
but controversial studies on this subject. Although it 
is a continuing investigation, the Oxford Study has 
already provided data that indicates that obstetric 
radiology as practiced some years ago in England 
increased the prevalence of childhood cancers in gen-
eral and more specificially the risk of leukemia. That 
risk appears to be a function both of the number ofx-
ray films taken while the fetus is in utero and the 
stage of fetal development. Four other studies in-
volving the effects of radiation on developing fetuses 
also indicate that obstetric radiology even to third 
trimester fetuses has probable deleterious effects. One 
study by Meyer, Tonascia, and Merz4 indicates that 
there is a 15% increase in fertility in young females 
exposed in utero and also a suggestion of differences 
in growth, development, and behavior between ex-
posed and control populations. Exposed women (in 
utero) have completed fewer grades of school, have 
poorer general health, more menstrual problems, 
more of certain diseases and accidents, and are heav-
ier for their height than the control population . Mul-
linex and her colleagues• working with rat fetuses 
irradiated in utero have observed significant changes 
in the behavioral activities of the rats that are ex-
posed as compared with controls. 
The major effect of very low doses of radiation 
on adult somatic cells is the induction of tumors. One 
of the difficulties of estimating the relationship be-
tween exposure to radiation and the induction of 
tumors is the long latent period between the induc-
tion and the growth of the tumors. There is little 
doubt, however, that tumors are induced by radiation 
at low-dose levels . The most common cancer induced 
appears to be leukemia possibly because no matter 
what area of the body is irradiated, circulating pe-
ripheral cells are always exposed and exposed fre-
quently. To understand. the risks involved in radia-
tion exposure, one must remember that the dose of 
radiation calculated to double the natural incidence 
of diseases as a consequence of radiation exposure 
(the doubling dose) is somewhere between 20 rem 
and 200 rem . A rem is the absorbed dose in rads 
multiplied by modifying factors such as tissue sensi-
tivity and the penetrating or ionizing qualities of the 
radiation in .question, with the test or biomedical 
endpoint being measured. For most purposes one can 
substitute the radiation absorbed dose (rad) for rem : 
One rad equals an absorbed deposition of energy 
equivalent to iOO erg/ gm of tissue. The maximum 
permissible exposure to non-radiation workers is 0.5 
rads per year. Radiation exposures associated with 
typical diagnostic procedures such as chest films, gas-
troiritestinal series or an intravenous pyelogram 
(IVP) are usually weli under the permissible dose, the 
exception being the doses associated with the diagno-
sis and treatment of serious diseases. Most people 
never are exposed to as much as 20 rads of ionizing 
radiation in a lifetime. Even then the risk would be 
low but riot insignificant since a 5 rem gonadal dose 
per generation to a population would increase disease 
due to mutation from 0.5% to 5.0% at equilibrium in 
the population. 
The questions regarding the advisability of ex-
posure to radiation are almost always those of risk vs 
benefit. Reasonable answers can be made only by 
using care, judgment and flexibility . Mutagenic 
agents are ubiquitous in the environment; they are 
always dangerous, but in many instances the benefits 
outweigh the risks associated with exposure. If a nor-
mal incidence of a disease or condition is I I I 00,000 
individuals, doubling the risk only increases it to 2/ 
I 00,000. That risk is not meaningless, but in many 
instances it is low enough to negate concern when 
reasonable benefit is to be derived from exposure. 
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Juvenile Hyperlipemia 
WILLIAM W. MILLER, M.D., Professor of Pediatrics 
Asymptomatic hyperlipemia occurs in a signifi-
cant number of American children. It is important to 
recognize the condition during childhood because of 
its role as a risk factor in the early onset of coronary 
artery disease and because early dietary modification 
may prevent changes leading to premature heart dis-
ease. 
A predisposition to heart attack exists within 
families, and now there is significant documentation 
of familial aggregations of coronary atherosclerosis 
as a concomitant of genetically determined risk fac-
tors such as hyperlipemia, hypertension, and diabetes 
mellitus. 1 - 3 Of these three conditions, hyperlipemia, 
which often displays a clearly genetic component, is 
related most directly to the pathogenesis of athero-
sclerosis. 
The following review will present the character-
istics of juvenile hyperlipemia, note the known ge-
netic influences, document its prevalence in children 
in the United States, and present recommendations 
for diagnosis and management. 
Hyperlipemia is the manifestation of a variety of 
biochemical abnormalities producing hypercholester-
olemia and/or hypertriglyceridemia, both of which 
are associated with an increased risk of coronary 
artery disease in adults. Because hyperlipemia occurs 
in early childhood and may lead to coronary athero-
sclerosis, the identification and treatment of children 
with hyperlipemia should receive more attention than 
it does at present. The definition of hyperlipemia is 
indistinct; normal blood levels of cholesterol and tri-
glycerides are defined statistically by measurements 
in apparently healthy children. Although the levels 
can vary geographically and may be influenced by 
diet and other factors, "normal limits" have generally 
been based on 90th percentile fiducial limits calcu-
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lated from relatively small samples (Table 1 ).4 A di-
agnosis of hyperlipemia is justified if lipid or lipopro-
tein concentrations, measured after a 12-hour fast, 
are above these "riormal limits" on three separate 
occasions at least two weeks apart. Both cholesterol 
and triglyceride serum concentrations increase gradu-
ally throughout childhood and adolescence. Al-
though the studies are limited, the normal range of 
cholesterol levels appears to be relatively narrow ex-
cept during the first year of life when serum choles-
terol is especially affected by the type of fat in the 
diet; consequently, unless the parents are hyper-
lipemic, diagnostic and therapeutic decisions are best 
delayed until after six months or one year of age, 
when a more mixed source of dietary fat is usual and 
there is a diminished variation of serum lipid concen-
trations. The changes in serum triglyceride concen-
trations during childhood are less well defined than 
are those for cholesterol, although a gradual increase 
is commonly observed. In children with persistent 
hyperlipemia, serum lipoprotein should be estimated 
by electrophoresis, and a survey of other family mem-
bers is indicated. These additional studies can greatly 
facilitate a precise diagnosis when it is possible to 
demonstrate similar findings in a parent or sibling. 
The most widely used classification of hyper-
lipemic diseases is based upon the serum lipoprotein 
pattern since blood lipids are bound to lipoproteins. 
The term "hyperlipoproteinemia" is therefore often 
preferred over " hyperlipemia" or " hyperlipidemia." 
Six types of primary hyperlipoproteinemia are seen in 
adults; all except type III have been detected in child-
hood or adolescence. A useful classification of juve-
nile hyperlipoproteinemia is illustrated in the Figure. 
Hyperlipoproteinemia I, also known as familial 
hyperchylomicronemia or lipoprotein lipase defi-
ciency, is a rare autosomal recessive trait. The bio-
chemical defect is a deficiency of the enzyme, lipopro-
tein lipase. In homozygous children the disease is 
usually characterized by elevated cholesterol and tri-
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TABLE 1 
Upper Limits of "Normal" of Plasma Lipid and Lipoprotein Cholesterol Concentrations (mg/ 100 ml) in Infants, Children and Adolescents 
AGE 
CORD BLOOD 
1-19 yr 
TOTAL 
C HOLESTEROL 
95 
230 
TRIGLYCERIDE 
65 
140 
glyceride levels, a deficiency of lipoprotein lipase ac-
tivity in post-heparin plasma or adipose tissue, chy-
lomicron uptake in the skin and reticuloendothelial 
tissue, abdominal pain, and pancreatitis which may 
be fatal. In children with xanthoma or pain the diag-
nosis is clinically obvious. However, in many children 
who are asymptomatic the diagnosis may be made 
LIPOPROTEIN LI POPROTE IN LIPOPROTEIN SERUM 
PHENOTYPE ELECTROPHORETIC ABNORMALITY CHOL. 
PATTERN 
1111 I I Chylomicrons t 
Chylomicrons 
IIA II 11 II t LDL ttt 
Beta 
IIB 11 II I I t LDL ttt 
Beta + Pre-Beta t VLDL 
III 11 I 
Broad Beta I I Abn LDL Abn ~-VLDL ttt 
IV II II I I t VLDL +or -
Pre-Beta 
v II II I I Chylomicrons +++ 
Chylomicrons t VLDL 
+ Pre-Beta 
HDL C HOLESTE ROL 
LDL CHOLESTEROL MALE FEMALE 
45 
170 
55 
65 
55 
70 
accidentally by a finding of milky plasma, hepatos-
plenomegaly, or lipemia retinalis. Premature athero-
sclerosis has not been documented in these patients; 
however, the other symptoms and debilitating nature 
of the disease make treatment mandatory. 
Hyperlipoproteinemia II, also know as familial 
hypercholesterolemia or familial hyperbetalipopro-
LIPIDS 
TRIGLY. 
tttt 
tt 
ttt 
ttt 
tttt 
PRIMARY SECONDARY 
Familial Diabetes mellitus 
hyperchylomicronemia 
Familial Hypothyroidism 
hypercholesterolemia Nephrotic syndrome 
Obstructive jaundice 
Fami 11 al Hypothyroidism 
hypercholesterolemia Nephrotic syndrome 
Obstructive jaundice 
Familial Hypothyroidism 
dysbetalipo-
proteinemia 
Familial Diabetes mellitus 
hyperglyceridemia Nephrotic syndrome 
Glycogenosis (III) 
Hypothyroidism 
Familial Diabetes mellitus 
hypertriglyceridemia Nephrotic syndrome 
Pancreatitis 
Figure-Phenotypic classification of hyperlipoproteinemias. 
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teinemia, is inherited as an autosomal dominant trait. 
It is the most common form of juvenile hyperlipemia 
a nd is associated with a high risk of premature coro-
nary artery disease. Hyperlipoproteinemia II ac-
counts for many adults with myocardial infarction. 
Biochemical abnormalities are now believed to be the 
result of an absence or deficiency of a low-density 
lipoprotein receptor on cell membranes.5·6 
The relatively common heterozygous form, hy-
perlipoproteinemia II A, has an estimated prevalence 
of four per thousand7; in a Seattle study approxi-
mately one out of every twenty adult survivors of 
myocardial infarction was found to have this condi-
tion8; in a similar study 38 of 64 survivors had abnor-
mal lipoprotein patterns.9 These hyperlipemic fa-
thers, all under 41 years of age, had 85 children of 
whom 30 also had hyperlipoproteinemia II. Hetero-
zygous infants have plasma cholesterol levels that are 
two to three times normal by the end of the first year 
of life. In matings between a heterozygous and a 
normal parent, the affected children can be identified 
at birth by cord-blood elevations of low-density lipo-
protein cholesterol to values greater than 41 mg/ JOO 
ml. 10 Tendinous xanthoma, corneal arcus, and coro-
nary artery disease develop in young adults, usually 
from 20 to 30 years of age. In about I 0% of children 
with type II disease, there are mildly elevated levels of 
very low-density lipoproteins and triglycerides along 
with elevations in low-density lipoprotein choles-
terol.11 This less common variation is classified as 
familial hyperlipoproteinemia II B.12 
Homozygous children, who inherit a double 
dose of the mutant gene, are much more severely 
affected; the disease is often suspected initially be-
cause of the strong family history of heart disease. 
Cholesterol levels, which may range from 500 to JOOO 
mg/ JOO ml, are frequently markedly elevated even at 
birth, and corneal arcus and xanthoma appear before 
adolescence. Coronary artery disease is clinically ap-
parent before the age of 20 and survival beyond 30 is 
rare. 
In every family with a member who h as experi-
enced a heart attack before the age of 50, serum 
cholesterol and triglyceride levels should be measured 
in all first-degree relatives. Those with normal lipid 
values can be reassured about lipid risk factors and a 
significant number of those with hyperlipemia can be 
identified and treated early. 
Hyperlipoproteinemia III , also known as "broad 
Beta disease," "floating Beta disease," or dysbetali-
poproteinemia, has not been detected in children, 
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as noted previously. Inheritance is probably either 
an autosomal recessive or an autosomal dominant 
with incomplete penetrance.13 The condition results 
in elevated levels of cholesterol and triglycerides with 
an abnormal cholesterol to triglyceride ratio in the 
very low-density lipoprotein .14 
Hyperlipoproteinemia IV, is relatively rare in 
children and is also referred to as familial hyper-
triglyceridemia or endogenous hypertriglyceridemia. 
Triglyceride levels a re always elevated, ranging from 
150 to 1000 mg/ JOO ml, and in about 20% of patients 
the very low-density lipoprotein levels may result in a 
hypercholesterolemia, with levels up to 350 mg/ JOO 
ml.15 Clinical findings commonly include non-ketotic 
diabetes and, less commonly, subcutaneous xan-
thoma. Obesity and hyperuricemia are frequent. A 
significant proportion of adults under the age of 50 
with angina or myocardial infarction have primary 
type IV disease. 15 The condition appears to be hetero-
geneous. The biochemical abnormality is not known, 
but studies suggest a defect in very low-density lipo-
proteinemia catabolism.16·17 It may occur in relatives 
of patients with type III or type V lipoprotein abnor-
malities13 and in some families genetic transmission 
follows an autosomal dominant pattern with delayed 
expression. 
Hyperlipoproteinemia V is rare in childhood. 
Triglyceride levels range from 500 to 6,500 mg/ JOO 
ml and cholesterol varies from 150 to 1,500 mg/ JOO 
ml. Clinical findings are similar to those with type I 
disease. Type V disease does not lead to premature 
atherosclerosis; it is frequently associated with obe-
sity, hyperuricemia, and abnorma l glucose tolerance. 
The inheritance of the primary disease is not known; 
a family history of diabetes is common and there is a 
high prevalence of type IV disease in first-degree rela-
tives. 
Many chronic childhood diseases are associated 
with secondary hyperlipemia (Figure). Although in-
fants with hypothyroidism usually have normal lipids 
and lipoproteins, in older children hypothyroidism is 
often associated with hypercholesterolemia which 
can be reduced by adequate thyroid treatment. Most 
children with the nephrotic syndrome have hyper-
cholesterolemia, with close inverse correlations be-
tween cholesterol and albumin levels. In children 
treated by renal dialysis, the practice of feeding high 
fat diets to provide sufficient calories for growth may 
result in secondary hyperlipoproteinemia and accel-
eration of atherosclerosis. Children with hepatic gly-
cogenosis III have hyperlipoproteinemia, usually 
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with increases in very low-density lipoproteins. Since 
many of these children survive to adulthood, early 
modification of the hyperlipemia by diet is indicated. 
Children with obstructive liver disease often have 
hyperlipemia unless the disease is at an advanced 
stage. Diet a nd drug management of the hyper-
lipemia result in diminution in the symptoms and 
lesions of xanthomatosis. In adolescents and young 
adults other rare causes of hyperlipemia are preg-
nancy, alcoholism, adrenal disease, and the chronic 
administration of adrenal corticosteroid drugs. 
Dietary restriction and selection of fats is in-
dicated in all children with primary hyperlipemias 
(Table 2). Because skin xanthoma are diminished or 
eliminated in children undergoing treatment, it is rea-
sonable to conjecture that regression of vascular lipid 
deposits, with a concomitantly decreased risk of cor-
onary artery disease, also occurs. In type I disease a 
low-fat diet normalizes serum lipids and reduces or 
prevents abdominal pain and pancreatitis. In type II 
disease a low-fat, low-cholesterol diet with a high 
ratio of polyunsaturated to saturated fats normalizes 
lipids in type II A patients, reduces lipid levels signifi-
cantly in type II B children, and diminishes xanthoma 
in both. In type IV children a low-calorie, weight-
reduction diet is sufficient to normalize serum lipid. 
In children with type V disease a low fat, moderate 
cholesterol diet normalizes serum lipids and prevents 
abdominal pain. 
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A low-cholesterol diet, 100 to 150 mg/ 100 ml, is 
achieved by eliminating egg yolk, organ and fatty 
meats, and shellfish, substituting skim milk and low-
cholesterol margarine for whole milk and butter, us-
ing only cottage cheese among the cheeses and pro-
hibiting products with coconut oil in them.18 
Diet management alone is inadequate in 85% of 
type II children, and it is often necessary to u·se 
cholestyramine, a nonabsorbable anionic resin and 
bile acid sequestrant, which produces an exchange of 
chloride ions for bile acids in the intestine. The acids 
are excreted in the feces, and the reduction in enzyme 
product inhibition increases the endogenous metabo-
lism of cholesterol, resulting in diminished serum 
levels of very low-density and low-density lipoprotein 
cholesterol. In doses of 250 to 800 mg/ kg/ day, cho-
lestyramine does not cause malabsorption, although 
constipation, epigastric discomfort, and bloating are 
common. Because the drug absorbs fat, it can also 
produce mild steatorrhea and poor absorption of fat 
soluble vitamins. Its disagreeable taste is masked by 
using fruit juice or incorporating it into cookies. The 
surgical treatment of children with type II disease by 
partial ilea! bypass is not recommended at this time. 
In homozygous type II B children, the prognosis 
for effective reduction in serum lipids is poor. Low-
fat diets a nd large doses of cholestyramine, together 
with the administration of nicotinic acid may be ef-
fective.19 Nicotinic acid, however, is often poorly tol-
TABLE 2 
Treatment of Primary Juvenile Hyperlipemia 
TYPE DIET 
Low fat (10-15 g/ day) 
Medium chain triglyceride 
II A HETEROZYGOTE Low cholesterol (100-150 mg/day) 
High polyunsaturated/ 
saturated ratio (2/ I) 
II B HOMOZYGOTE Low cholesterol (100-150 mg/ day) 
High polyunsatu rated/ 
IV 
v 
saturated ratio (2/ 1) 
Low calorie weight control 
Low fat (20-30 g/ day) 
Moderate cholesterol 
(300-400 mg/ kg/ day) 
Medium chain triglyceride 
DRUG 
Cholestyramine 
(250- 800 mg/kg/ day) 
Cho lestyramine 
500- I 500 mg/ kg/ day 
Nicotinic acid 
25-75 mg/ kg/ day 
EFFECT 
Normalizes lipids 
Prevents pain and pancreatitis 
Normalizes lipids. Reduction of 
cardiovascular risk possible 
Lowers lipids, Xa nthoma diminish. 
Reduction of cardiovascular 
risk possible 
Norma lizes lipids. Reduction in 
cardiovascula r risk possible 
Normalizes lipids prevents pain 
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erated because of such side-effects as flushing , gastro-
intestinal distress, temporary hyperuricemia, glucose 
intolerance, or hepatic dysfunction. 
Nationwide reductions in dietary fat and choles-
terol intake have been promulgated by various health 
organizations. Most advisors recommend a reduction 
of individual fat intake from 40% to 30% of the total 
calories and a decrease in cholesterol and saturated 
fats. 
Juvenile hyperlipemia is relatively common in 
the United States, and most affected children are 
asymptomatic. Measurements of serum cholesterol 
and triglycerides are indicated in all infants and chil-
dren in families with one or more members having a 
heart attack before the age of 50, because a signifi-
cant proportion of these children will have hyper-
lipemia and will require dietary restrictions, and 
some will need drug treatment. Early recognition and 
management of juvenile hyperlipemia may diminish 
the incidence or severity of coronary artery disease 
decades later. 
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V. RESEARCH 
New Approaches to the Use of Twins in 
Biomedical Research 
WALTER E. NANCE, M.D., PH.D., Professor of Human Genetics, Pediatrics, and Medicine 
Human genet1c1sts are often accused of being 
preoccupied with exotic syndromes that are of mar-
ginal relevance to the general population. Brilliant 
success has been achieved during the past two dec-
ades in defining the nature and function of the genetic 
material, the molecular pathology of a large number 
of metabolic diseases, the phenotype of inore than 
2,000 Mendelian traits, and more recently the 
chromosomal location of a rapidly expanding num-
ber of human gene pairs. In contrast, relatively little 
progress has been made in the genetic analysis of 
quantitative traits such as blood pressure, serum cho-
lesterol, intelligence quotient (IQ), skin color, height, 
birth weight, or glucose tolerance. Traits of this type 
are not only of interest to society, but may also relate 
significantly to a variety of common diseases. With 
almost every continuously distributed quantitative 
trait, single gene defects have been identified which 
can profoundly alter the phenotype. For example, the 
single gene pairs which determine albinism and Tay-
Sachs disease can profoundly alter skin color and IQ 
respectively. However, the causes of less extreme var-
iation can be exceedingly complex, resulting from the 
cumulative effects of many gene pairs and their inter-
actions with each other and with the environment. 
Nevertheless, even if the effects of individual gene 
pairs cannot be identified, the source of the observed 
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variation may often be inferred from an analysis of 
the phenotypic correlation of relatives of various de-
gree. Twin studies have been widely used in the past 
to gain insight into the inheritance · of quantitative 
traits, and with the support of a Program Project 
Grant from the National Institute of Maternal and 
Child Health, the Department of Human Genetics at 
the Medical College of Virginia has become a leader 
in the use of twins for biomedical research. 
The basic idea of a classical twin study is to 
compare the differences between monozygotic (MZ) 
and dizygotic (DZ) twins. Since MZ twins arise from 
a single fertilized egg, they possess identical sets of 
nuclear genes, and differences between them are as-
sumed to arise from environmental causes. DZ twins, 
on the other hand, are genetically no more similar 
than siblings, sharing, on the average, only half of 
their genes. The extent to which the intrapair differ-
ences of DZ twins exceed those of MZ twins provides 
a measure of the importance of genetic factors as a 
cause for variation in DZ twins. DZ twins are consid-
ered to be an appropriate comparison group because 
they are born at the same time and are assumed to 
share the same environmental similarities as MZ 
twins . Classical twin studies remain a very useful 
method for estimating the relative importance of ge-
netic factors as a cause for variation in complex phys-
ical , physiological, or psychological traits . We have 
made extensive use of this approach to investigate 
the genetic control of bone mineral content, 1 dental 
and cephalometric variables, 2 •3•4 electrocardiographic 
variables,5 amino acid metabolism,6 dermatoglyphic 
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°T°~ OlJ 0 D 
F.ig !-Pedigrees of families of monozygotic twins. Lines below 
figures suggest how variation among the offspring may be parti-
tioned into arnong half-sibship, between sibship within half-sib-
ship, and within sibship components. Squares indicate males and 
circles, females. 
variables,7 and a variety of biochemical , physiologi-
cal, and psychological traits. 8 •9 •10 However, there ar,e 
a number of limitations in the classical twin model. 
The method does not permit the recognition of ma-
ternal effects or an incisive resolution of the geneti(l 
effects, and the assumption that the erivironmental 
similarities of identical and fraternal twins are equiv-
alent may be open to question for some traits. 
Also , in order to generalize the results, we must be 
willing to consider twins a random sample of the 
genotypes iri the general population. This.is probably 
a reasonaole assumption for ,, MZ twins; however, 
many genetic and environmental factors are known 
which profoundly influence the incidence of DZ twins 
and might, therefore, prevent direct extrapolation of 
the results of a twin study to the general population. 11 
Finally, ooth fraternal and identical twins may be 
exposed to. unique intrauterine environmental effects 
which need to be better understood in order to eval-
uate their possible significance as a source of bias in 
classical twin studies.9 
fo order to circumvent these problems, we have 
developed a powerful new m.odel for the analysis of 
quantitative inheritance in man which exploits the 
unique relationships that exist withiri the families of 
identical twins. 12 Because they have a genetically 
identical parent, the children of identical twins are 
related to each other in the same way as half-siblings 
(Fig 1). Genetically, the child of a twin is just as 
Closely related. tb his twin aunt or uncle as he is. to his 
twin parent. However, since the parents and their 
own children usually live in the same home, and are, 
for example, exposed to the same diet, we would 
expect any significant environmental similarities to 
make an additional contribution to the parentcoff-
spring correlation. It is easy to see how a comparison 
of the correlations would permit a clear separation of 
genetic and environmental effects on the closely re-
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lated half-sibs. Each family contains individuals who 
share one fourth of their genes (the half-sibs ), one 
half of their genes (the full sibs ), all of their genes (the 
MZ twins), and none of their genes (the spouses of 
the twins). These and other relationships permit the 
derivation of multiple line_ar equations in which an 
observed correlation, variance or covariance between 
family members is expressed as a linear combination 
of several unknown genetic and environmental vari-
ance components that we wish to estimate. Since the 
!IlOdel yields more equations than unknowns, we can 
solve the system of equations and obtain the best 
fitting estimates of the unknown parameters. The 
calculations are quite complicated, particularly since 
we rrii.Jst allow for the fact that our observed correla-
tions, variances, and covariances may not be inde-
pendent of one another because they have been de-
rived . from individuals who are interrelated in a 
complex manner. However, the use of a high-speed 
computer makes solution of the equations technically 
feasible. 
The entire process of parameters estimation can 
be summarized in matrix n_otation by the single equa-
tion, d = (M'V- 1M)- 1 M' v-1c. G represents the 
vector of unknown genetic variance components we 
wish to estimate; M represents the matrix of coeffi-
cients derived from Table 1; C represents the vector 
of the ob~erved meah squares; and V represents the 
variance/covariance matrix of the observed mean 
squares. Most physicians would probably find a 
detailed exposition of tfie mathematical analysis to 
be tedious and uninformative; however , the essence 
of the analysis is simple and intuitive, depending 
TABLE I 
Genetic Interpretation of Variance Components from 
Offspring Analysis of Variance 
Among haJfcsibship, 
male twins 
Between sibships, 
male twins 
With sibships 
Between sibships, 
female twins 
Among half-sibships , 
female twins 
Constituent genetic and 
environmental subcomponents 
1/ 4 0 l/ 16 0 0 0 
1/ 4 1/ 4 3/ 16 l 0 l 0 
1/ 2 3/ 4 3/ 4 0 0 0 
1/ 4 1/ 4 3/ 16 0 0 0 
1/ 4 0 1/ 16 0 0 
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TABLE 2 
Analysis of the Birth Weight of 254 Offspring of 46 Pairs 
of Identical Twins 
Estimate± Prbportion of total 
Parameter Standard Error variance(%) 
YAA 0.014 ± 0.037 6.4 
YM 0.075 ± 0.030 34.1 
YES 0.049 ± 0.020 22.2 
YEW 0.082 ± 0.028 37.3 
as it does upon the concept developed in high school 
algebra, that if you have as mahy independent 
equations as you have unknowns, a solution can be 
obtained. 
A unique feature of the model is that it permits 
the detection and estimation of genetically deter-
mined maternal effects. If intrauterine or postnatal 
maternal effects influence a trait to a significant de-
gree, we would expect the .offspring of identical fe-
male twins to be more similar than the offspring of 
male twins sinC'e the latter are born to genetically 
unrelated mothers. As suggested by Figure l, the 
total variability or variance among the offspring may 
be divided by a statistical procedure known as a 
"riested analysis of variance'.' into withih sibship, be-
tween sibship within half-sibship, and among half-
sibship components. Each of these components may 
be expressed in terms of a series of constituent genetic 
and environmental subcomponents (Table l ). In this 
formulation, VA refers tO the additive component of 
the genetic variance. Additive genetic effects are the 
ones responsible for the resemblance between parents 
and their offspring. The among half-sibship com-
ponent of variance is equivalent to the covariance 6f 
half-sibs and since half-sibs share one fourth of their 
genes, this component includes one fourth of the total 
variation attributable to additive effects, the remain-
der being distributed as shown in Table l. V AA refers 
to additive genetic effects that result from the inter-
action of gehes at separate loci. The term V0 refers to 
genetic effects that show dominance and arise from 
interactions bet:Ween the two members of a gene p~ir 
(alleles). Dominance effects cari contribute to the 
similarity only of individuals who are related to each 
other through both parents. For this reason, note 
that no dominance effects appear in the among half-
sibship component. YEH• VEs, and VEw refer to 
environmental effeets acting among haif-sibships, be-
tween sibships within half-sibships, and within sib-
ships respectivel,y. Finally, maternal effects are desig-
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nated by V M· Since they contribute to the similarity of 
the half-sib offspring of female twins, V M appears in 
the among half-sibship component for female twins. 
In the case of male twins, on the other hand, the 
maternal effects arising from the genetically unrelated 
wives contribute to variation between sibships within 
each half-sibship. The five relationships shown in 
Table 1 provide five of the equations which can be 
used in the overall analysis described previously. If 
the analysis is confined to these relationships, it be-
comes possible to exploit the unique genetic relation-
ship of moriozygotic twins through observations of 
their offspring without incurring any of the method-
ologic liabilities that might be associated with the 
inclusion of data from the twins themselves. 
Table 2 shows the results of an analysis of the 
birth weight of 254 children of 46 twin pairs. The data 
were collected by interviews and questionnaires, and 
prior to the analysis, the birth weights were adjusted 
for gestational age at the time of delivery. In all 
genetic models that fit the data well, there was evi-
dence that genetically determined maternal effects 
made a highly significant contribution to the overall 
variation in birth weight. In fact, our results suggest 
that at least one third of the total variation in birth 
weight is actually fixed or determined prior to the 
time of conception by the genotype of the mother! 
Since birth weight is highly correlated with feta l sur-
vival, these findings raise the possibility that perhaps 
we should look more closely at the mothers of high 
and low birth weight infants; in future extensions of 
the present work, we would like to repeat the analysis 
TABLE 3 
Distribution of Twins by Age, Sex, and Zygosity 
Age in years 
Type 0-10 10-20 20 Total 
MONOZYGOTIC 
Male-Male 15 II 6 32 
Female-Fem ale 14 3 10 27 
Total 29 14 16 59 
DIZYGOTIC 
Male-Male 9 0 10 
Female-Female 9 I 3 13 
Male-Female 21 2 2 25 
Total 39 4 5 48 
GRAND TOTAL 68 18 21 107 
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TABLE 4 
Distribution of Newborn Twins by Race and Placenta Type 
after dividing the families into high, low, and inte!-
mediate birth weight categories. We are currently 
trying to identify additional fertile adult MZ twins 
who would be suitable for inclusion in our MZ half-
sib studies . The project involves the collection of. a 
large amount of medical and genetic data from the 
families during an out-patient visit, and the partici-
pants are informed of any abnormalities that are 
detected in any of the blood, urine, or physiologic 
screening tests.* 
Black White Total 
Placenta type MZ DZ MZ DZ MZ DZ 
TWINS 
Monochorionic 
monoamnionic I 0 0 0 
Monochorionic diamnionic 6 0 2 0 
Dichorionic, fused 4 0 4 
Dichorionic, separate 16 0 5 
TRIPLETS 
Monochorionic triamnionic 1 0 0 0 
Trichorionic 0 0 0 
TOTAL 10 21 2 9 
Pedigrees 
#1020' 
1 
8 
1 
0 
12 
0 
0 
8 
21 
0 
30 
Biology of Twinning 
Since the new program of twin research was 
initiated at MCV, 107 twin pairs have been evaluated 
* Twins may be referred to the study by calling the Project Coor-
dinator, Phyllis Winter, at 804/ 770-4645. 
of Familial Twinning 
~J 
-----'-- #1794 #1353 
#1361 
Fig 2-Pedigrees of 15 families showing a history of twinning in close relatives. 
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and enrolled in the Twin Panel (Table 3). The sample 
includes 40 pairs of newborn twins and two sets of 
triplets ascertained from the MCV Obstetrical Ser-
vice. Systematic placental examinations have been 
performed in these twins (Table 4 ). It is now clear 
that monozygotic twins may have either two separate 
placentas or a single placenta. The former are all 
dichorionic while the latter include dichorionic pairs 
and monochorionic twins that may either be diam-
nionic or rarely monoamnionic. These differences in 
placentation are thought to reflect differences in the 
stage of embryonic life at which the twinning process 
occurred. One goal of the newborn twin study is to 
determine whether these striking placental differences 
are reflected in phenotypic differences between the 
twins. Preliminary evidence suggests that the intra-
pair differences in cord blood cholesterol in dicho-
rionic twins are more than five times as great as those 
observed in monochorionic pairs.9 
The twins studied to date have included 15 fami-
lies in which there was a history of twinning in a close 
relative (Fig 2). A genetic predisposition to dizygotic 
twinning has long been recognized, presumably medi-
ated by neuroendocrine differences in some women. 
For MZ twins, however, it is much less clear whether 
or not the occasional occurrence of familial aggrega-
tion indicates a genetic effect, and the cases shown 
(see Fig 2) do little to resolve this uncertainty. In 
family #1885, the birth of two sets of MZ twins to a 
woman by different fathers strongly suggests a mater-
nal influence, whereas family #1836, in which MZ 
twins were born to a member of a male MZ pair, 
suggests patrilineal inheritance. Finally, in family 
#1642, placental examinations were performed on 
both twin pairs, revealing monoamnionic placenta-
tion in one and diamnionic monochorionic placenta-
tion in the other-a finding which suggests that famil-
ial occurrence is not confined to twins of a single 
placenta type. 
Summary 
The MCV Twin Panel was begun in 1976 and 
includes twins and higher order multiple births of all 
ages. Twin studies offer many opportunities for in-
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novative research, and it is intended that the Panel be 
a research resource for clinical investigators at the 
Medical Center. 
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Genetic Studies of Deafness and of Retinitis 
Pigmentosa 
JOANN A. BOUGHMAN, Graduate Assistant, Department of Human Genetics 
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In experimental animals where the generation 
time is short and matings can be controlled experi-
mentally, it is a relatively simple task to determine 
whether a trait is genetic, how it is inherited, and 
where the causal gene pair is located. However, in 
human genetics, inferences must be drawn by pooling 
observations on many small families in which the 
trait of interest has occurred. The condition may be 
etiologically heterogeneous, resulting from environ-
mental causes in some families and showing variable 
patterns of inheritance in others. Hereditary deafness 
and retinitis pigmentosa (RP) provide instructive ex-
amples of the problems involved in the genetic analy-
sis of family data in man. 
Hereditary Deafness 
It is now clear that the interactions of literally 
hundreds of genes are required to provide the infor-
mation needed to form a normal ear, and that a 
defect in any one of many genes can result in deaf-
ness.1 Well over 100 specific syndromes have been 
described showing dominant, recessive, and sex-
linked patterns of genetic transmission in which hear-
ing loss is a major fi nding.2 On the other hand, many 
environmental causes of deafness are known, such as 
rubella, prematurity, and ototoxicity, and in a given 
case, in the absence of a recognizable syndrome or a 
positive family history, it may be difficult to be sure 
whether the cause is genetic or nongenetic. 
The problem is complicated by the fact that hu-
This is paper #32 from the Department of Human Genetics of 
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man families are so small that with recessive deafness 
(the most common genetic type) there may be only 
one affected child in the family. Table 1 shows the 
expected proportion of families that would have no 
affected children, one affected child (simplex fami-
lies), and more than one affected child (multiplex 
families), with a recessive trait. The multiplex fami-
lies are the "obvious" genetic cases, and the task of 
the geneticist is to estimate what proportion of the 
simplex families are, in fact, genetic cases in which by 
chance only o ne affected child has occurred. The 
remaining simplex cases are sporadic; they arise from 
nongenetic causes and are not associated with an 
appreciable recurrence risk. The proportion of non-
genetic or sporadic cases is designated by the letter x. 
A second problem in the analysis of data from human 
families relates to ascertainment biases. In the case of 
a recessive trait, a large proportion of the families at 
risk will have no affected children (Table 1 ). Since 
there may be no way for us to discover these families, 
we must base our conclusions about the expected 
proportion of affected children on an incomplete or 
truncated sample of families which has been ascer-
tained because there has been at least one affected 
child in the family . In order to accurately estimate the 
recurrence risk, we must allow, in an appropriate 
manner, for the families with no affected children 
that we had no way of discovering. 
The parameter 7r is the probability that an af-
fected individual will be independently discovered by 
the sampling procedure. The value of 7r can vary from 
nearly zero to one and is a measure of the complete-
ness of the sampling procedure. Finally, we wish to 
estimate p, the recurrence risk or segregation ratio. If 
the estimate of p is close to 0.25, we might conclude. 
MCV QUARTERLY 13(4): 170-174, 1977 
BOUGHMAN ET AL: GENETICS OF DEAFNESS AND RETINITIS PIGMENTOSA 171 
TABLE I 
Expected Proportion of Families with no Affected, 
One Affected, and Multiple 
Affected Offspring in Matings 
Between Carriers of a Recessive Gene. 
FAMILIES WITH AFFECTED 
FAMILI ES C HILDREN (o/o ) 
WITH NO 
NUMBER OF AFFECTED MORE 
CHILDREN CH ILDRE N O N E THAN ONE 
IN FAMILY (%) (SIMPLEX) (MULTIPLEX) 
75 25 0 
2 56 37 7 
3 42 42 16 
4 32 42 26 
5 24 40 36 
6 18 35 47 
7 13 31 56 
8 10 27 63 
that the data agreed satisfactorily with the hypothesis 
of recessive inheritance. 
The process by which the three parameters ?r, x , 
and pare estimated is known as segregation analysis. 3 
With the use of a high-speed computer, we can esti-
mate what values of x, ?r, and p provide the best 
explanation for any given set of data containing in-
formation on the number of affected and normal 
individuals and index cases in each of a large series of 
families. 
The results of segregation analysis of data from 
11 ,968 families of deaf children are shown in Table 2. 
In the first line we see that in the case of 86 con-
sanguineous matings, the hypothesis of recessive in-
heritance with no sporadic cases (that is, p=0.25 and 
x=O.O) provides a satisfactory explanation for the 
data. The relatively low X2 values in the last two 
columns indicate a good fit of the hypothesis to the 
data. This means that whenever we elicit a history of 
consanguinity, it is safe to assume that we are dealing 
with recessive deafness even if there is only one af-
fected child in the family. This result is not surprising 
since parental consanguinity is the hallmark of reces-
sive inheritance. When present, it may indicate that 
the affected child has inherited two copies of the same 
rare recessive gene carried by one of the common 
ancestors of the parents. 
In the second and forth lines, we see that the 
hypothesis that all of the children in 11 ,900 non-
consanguineous matings have recessive deafness is 
resoundingly rejected as indicated by the enormous 
X2 values. However, when we allow x to assume the 
best fitting value of 0.6 in the families with a negative 
family history, the hypothesis that the remaining 
cases are recessive (that is, p=0.25) fits very well 
indeed (line three) . This tells us that among these 
nonconsanguineous families, 40% are genetic and 
probably recessive while 60% are nongenetic. It is of 
considerable interest that among families in which 
there was a remote history of deafness, in a grand-
parent, aunt, uncle, or a cousin for example, the 
estimated proportion of sporadic or nongenetic cases 
was much smaller (x=0.2), as shown in line five. 
Similar analysis can be performed for deaf children 
arising from deaf by normal matings, which presum-
ably are attributable to dominant inheritance, as well 
as for affected children arising from deaf by deaf 
matings, which may include both dominant and re-
TABLE 2 
Results of Segregation Analysis on 11,986 Hearing X Hearing Matings with Deaf Children (7r = 0.325) 
N UMBER OF CHILDREN 
MATING TYPE AND 
HYPOTHESIS TESTED 
Hearing X hearing 
consanguineous 
H0 : p = 0.25, x = 0 
Negative family history 
H0 : p = 0.25, x = 0 
H0 : p = 0.25, x = 0.6 
Positive family history 
H0 : p = 0.25, x = 0 
H,: p = 0.25, x = .2 
NUMBER OF 
SIBSHIPS 
86 
10,509 
10,509 
1,391 
1,391 
DEAF 
150 
12,7 12 
12,712 
2,142 
2,142 
HEARING 
148 
28,739 
28, 739 
3,496 
3,496 
2.1 
5,289.6 
1.9 
97.0 
0.05 
x 2 x 
3.4 
5,832.8 
103.9 
172 BOUGHMAN ET AL: GENETICS OF DEAFNESS AND RETINITIS PIGMENTOSA 
TABLE 3 
Summary Results of Segregation Analysis in 12,661 Informative Families with Deaf Children. 
NUMBER OF NUMBER OF 
MATING TYPE FAMILIES DEAF CHILDREN 
Hearing X hearing 11,986 15,004 
DeafX hearing 254 478 
DeafX deaf 421 989 
TOTAL 12,661 16,471 
% of Total 
% of Genetic 
cessive phenotypes. Table 3 provides a tally sheet for 
the segregation analysis of a large sample of l 6,4 7 l 
deaf children. Although there were multiple affected 
children in only about 6% of the families, it can be 
seen that our best estimate is that almost exactly half 
of the cases are in fact genetic in etiology. Most 
educators and physicians who work with the deaf 
find this estimate to be surprisingly high. Few 
otolaryngologists consider themselves to be geneti-
cists in spite of the fact that half of the young children 
they see with profound hearing loss are deaf because 
of genetic reasons. The frequency of patients with 
simply inherited genetic traits in this group is actually 
larger than that observed among children who are 
referred to a typical human genetics clinic for evalua-
tion and counseling.' 
Unfortunately, it is not always possible to iden-
tify those simplex cases that are genetic. As an aid to 
diagnosis in these cases, we have begun to establish a 
Genetic Registry of Hereditary Deafness. The Regis-
try is based upon pedigree data from a sample of 
about 5,000 matings among the deaf that were col-
lected by E. A. Fay, a professor of Gallaudet College 
in Washington, D.C., before the turn of the century. 
The Registry contains detailed information on about 
30,000 individuals that was collected by Fay and is 
supplemented by data on current pedigrees. In about 
7% of patients with genetic deafness, we find that it is 
possible to establish a geneologic linkage with some-
one listed in the Registry. Thus in some cases, use of 
the Registry can help establish the genetic nature of 
the disorder in situations where it might not be ap-
parent from the clinical evaluation or the immediate 
family history. 
The Registry should also promote the recogni-
tion of genetic heterogeneity which, as previously 
mentioned, is known to be extensive in hereditary 
CHILDREN WITH GENETIC DEAFNESS 
CHILDREN WITY 
SPORADIC DEAFNESS RECESSIVE DOMINANT 
8,126 6,650 228 
0 0 478 
0 451 538 
8,126 7,101 1,244 
49.3 43.1 7.6 
85.1 14.9 
deafness. An autosomal recessive form of hereditary 
deafness known as Usher syndrome provides an ex-
cellent example of heterogeneity even within a single 
clinical entity. In this condition affected persons suf-
fer from progressive blindness due to retinitis pig-
mentosa (RP) in addition to sensorineural hearing 
loss. Our studies suggest that the classic delineation 
of Usher syndrome with early-onset, severe sensori-
neural deafness and RP may have to be modified. 
We are collecting data on affected individuals 
using two different methods of ascertainment. The 
first involves ophthalmologic screening of students in 
schools for the deaf. About 4% to 6% of this group 
have an associated RP. Since these students tend to 
have severe hearing loss, our ascertainment is biased 
with regard to degree of hearing loss. To circumvent 
this problem we are also documenting the hearing 
status of a population of affected patients identified 
through the National Retinitis Pigmentosa Founda-
tion. Our preliminary data indicate that considerable 
clinical and genetic heterogeneity exist in these fami-
lies.5 Of great interest is the disparity in degree of 
hearing loss in probands and their affected sibs in the 
multiplex sibships. Table 4 shows that in 29 sibships 
TABLE 4 
Hearing Loss in Affected Sibs of Probands 
DEGREE OF HEARING LOSS IN AFFECTED 
DEGREE OF SIBS OF PROBANDS* 
HEARING LOSS 
IN PROBANDS NONE MILD SEVERE 
Mild 21 8 0 
Severe 8 6 I 
* numbers refer to sibships 
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TABLE 5 
Syndromes Characterized by Retinitis Pigmentosa (RP) 
MODE OF 
NAME INHERITANCE SOME TYPICAL FINDINGS 
Usher 
Refs um 
Bassen-K ornzweig 
Laurence-Moon-
Bardet-Biedl 
Cockayne 
AR 
AR 
AR 
AR 
AR 
Profound deafness; RP 
Neuropathies; EKG 
abnormalities; ichthyosis; 
deafness; RP; hyposmia 
Abetalipoproteinemia; 
RP; acanthocytosis; 
gastrointestinal disease 
Mental retardation; 
obesity; polydactyly; 
hypogonadism; RP 
Dwarfism; mental 
retardation; hearing loss; 
unusual facies; RP; 
dermatitis 
the probands had either mild or severe hearing loss, 
but the sibs affected with RP had no hearing loss; and 
in six sibships the probands reported severe hearing 
loss while the sibs had only a mild loss. 
Thus Usher syndrome may represent only part 
of a broad clinical spectrum of disability involving 
these two sensory modalities, and our Registry 
should not only promote the recognition of such 
heterogeneity but improve the quality of medical , 
genetic, and educational research on such diseases by 
providing rosters of affected individuals who are etio-
logically homogeneous. 
Retinitis Pigmentosa 
The term retinitis pigmentosa refers to a group 
of genetic disorders in which there is a progressive 
loss of vision associated with a characteristic pig-
mentary degeneration of the retina, nyctalopia, and 
progressive loss of peripheral vision, often leading to 
blindness. The genetic heterogeneity of this group of 
disorders is well documented. First, it is known that 
RP may be inherited in all three Mendelian modes: 
recessive (80% to 90% of cases), dominant (5% to 
10%), and X-linked (1% to 5%).6 Second, several 
specific genetic syndromes, of which RP is a part, 
have been identified (Table 5). More evidence for 
genetic heterogeneity comes from the study of many 
animal models for RP which indicate that the phe-
notype seen in these degenerative disorders may be 
produced by various primary lesions.7 
In collaboration with the Na ti on al Retinitis Pig-
mentosa Foundation, we are conducting a nation-
wide survey in order to clinically and genetically 
characterize a sample of pro bands with RP. System-
atic questionnaire data on family history, age of onset 
and progression of the symptoms, and associated ab-
normalities, have been analyzed on 670 individuals, 
forming a data base of 12,348 members of families 
including 1,390 affected individuals . 
Nyctalopia was the most frequently noticed first 
symptom, especially in the younger age groups. The 
most common extraocular finding was hearing loss, 
reported by 30.4% of the pro bands, 10.6% indicating 
their loss was severe. This finding in our large pro-
band sample reemphasizes the association between 
hearing loss a nd RP. 
Segregation analysis has been performed on 405 
informative proband sibships with no recognizable 
syndromes. Table 6 summarizes the results of these 
analyses, showing estimates of the segregation fre-
quency and proportion of sporadic ( nongenetic) 
cases. The estimate of penetrance in the case of the 
dominant mode of inheritance was 0.58. The finding 
of a low segregation ratio fo r both the recessive and 
dominant forms of RP is not surprising in view of the 
natural history of these disorders. The decreases in 
these ratios reflect the fact that the age of onset may 
not have been reached by many sibs, the median 
onset age for probands being nearly 15 years. Perhaps 
TABLE 6 
Segregation Analysis on Retinitis Pigmentosa Sibships 
NUMBER OF PROPORTION 
MATING TYPE SIBSHI PS SEGREGATION RA TIO SPORADIC CASES PENTRANCE 
Normal X Normal Nonconsanguineous 312 0.17±.06 0.11 
Normal X Normal Consanguineous 18 0.45±.12 0 
Normal X Affected 71 0.29 ± .04 0 0.58 
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the most significant finding from the segregation 
analysis is the evidence it provides that a small pro-
portion of the cases are nongenetic in etiology. 
In conclusion, genetic registries, such as the one 
described in this article, could have a nationwide 
impact on the diagnosis of hereditary disease and on 
genetic counseling for affected individuals and their 
families. Our research applies an innovative tech-
nique for the diagnosis of genetic diseases that could 
serve as a prototype to demonstrate the practical 
value of categoric genetic registries. This research will 
almost certainly lead to the recognition of new forms 
of hereditary deafness and retinitis pigmentosa which 
could be the first step in the development of specific 
therapies. 
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The Genetic and Environmental Effects on 
Diabetes in Humans and Animals: An 
Overview 
ROGER M. LORIA, PH.D., Assistant Professor, Departments 'of Microbiology and Pathology 
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Despite intense scrutiny the precise etiology of 
diabetes mellitus remains unclear . There appear to be 
two major forms of diabetes: juvenile-onset or in-
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~ .' 
sulin-dependent diabetes, and late-onset or irisulin-
independent d.iabetes 1•2; the late-onset form, in itself, 
may be etiolbgically heterogenedus. 3 Either form may 
occur at any age, with a ciear distinction between the 
two often being difficult to rriake. Juvenile-onset dia-
betes, representing 5% to 10% of all cases, is charac-
Mcv QUARTERLY 13(4): 174-17~ ; 1977 
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terized by abrupt qnset, clinical manifestation of hy-
perglycemi~ and ketoacidosis, and generally by a 
requirement for exogenous insµlin; in maturity-onset 
diabetes plasma levels of insulin are usually normal 
or elevated and the abnor'rnality in gluco&e metabo-
lism re&ults from a decrease in the number of insulin 
receptors rather than a deficiency of the hormone 
itself. 
Genetics of Diabetes in Man 
· It is generally accepted that there is an hert?diH!fM 
predisposition to diab.etes, but there is little 'cagr~!ef: 
ment as to its mode of inheritance. Early investiga~ 
tors concluded that diabetes was inhe~ited in a ~ii'npfe 
Mendelian fashion, probably as an autosomal rece~­
sive trait.4 Subsequent studies, however, suggest that 
diabetes may be controlled by a number of genes 
whose final expression is influenced to varying de-
grees by the environment.5 It is still impossible to 
resolve the multifactorial versus monogenic con-
troversy from the data and analytical methodologies 
. . . 
now available. Diabetes is undoubtedly hetero-
geneous and this fact, as well as the late age of onset 
in many cases, greatly complicates genetic analysis. 
For eirnmple, striking differences in concordance rate 
among identical twin pairs who have late-onset dia-
betes (92%) compared with identical twins with early-
onset diabetes (52%) provide strong evidence that the 
two forms are etiologically distinct.6 Concordant ju-
venile-onset pairs also had a positive family history of 
diabetes more frequently than discordant pairs, sug-
gesting that some cases are predominantly genetic, 
and others environmental, in etiology.a 
Genetics of Spontaneous Diabetes Mellitus in Animal 
Models 
A variety of animal models with spontaneous 
diabetes mellitus have been reported in the literature6 • 
1.s (Table I). Apparently many different mutations 
can lead to spontaneous diabetes. Simple autosomal 
recessive inheritance is displayed in db/ db, ob/ ob, 
TABLE I 
Genetics and Pathophysiological Changes in Animals with Spontaneous Diabetes 
Mutation & 
Chromosome Hyper- Elevated Serum Changes 
Animal Name number Inheritance Obesity glycemia Insulin Ketosis in Islet 
Diabetes db/ db Autosomal recessive ++ +++ transient+ ++ ++ 
C57BIKs 4 
Obese ob/ob Autosomal recessive ++ + ++ ++ 
C57B I/6 6 
Yellow A Va Autosomal dominant ++ + + + 
KK mouse Polygenic + + + 
NZO Polygenic ++ + + + 
PBB/ Ld Polygenic (?) ++ + 
C,HfX I Hybrids (fi) + ++ + + 
Spiny mouse Polygenic + +++ ++ + ++ 
Sand rat Polygenic + +++ transient + + 
Zucker rat fa/ fa Autosomal recessive ++ + + 
Chinese hamster Polygenic (4 genes) +++ transient ++ + 
S. African hamster Polygenic +++ (?) + + 
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and fa/fa rodents; autosomal dominant AY inher-
itance is apparent in the yellow mouse; and finally, 
polygenic inheritance has been invoked for the KK, 
NZO, PBB/ Ld mice strains, rats, and hamsters. 
The clinical syndromes expressed by these ro-
dent models will in most cases involve obesity and/ or 
hyperglycemia as seen in the db/db, ob/ob mice, and 
the fa / fa rat with or without ketosis; hyperglycemia 
without obesity is evident in the Chinese and South 
African hamster; while marked obesity without overt 
diabetes was displayed in ob/ ob, AY, NZO, PBB/Ld 
mice, and the Zucker rat. This wide range of symp-
toms illustrates the difficulty in determining whether 
genetic, environmental or maternal factors are the 
primary determinants in this disease. 
It now seems clear that even where diabetes is 
associated with a specific mutation, that is, db/db in 
the C57B I /KsJ mouse, other genetic and/ or environ-
mental factors, such as genetic modifiers or viral in-
fection, may be crucial in initiating this disease. The 
ob/ ob (obese) mutation in the C57Bl / 6J inbred 
mouse leads to obesity without diabetes . Transfer of 
this mutation to the C57Bl/Ks inbred mouse strain 
resulted in a C57B 1 / Ks ob/ ob animal with a meta-
bolic disorder strikingly similar to the diabetic mu-
tant (db/ db) itseJf.9 These results clearly indicate that 
two separate mutations which are known to be lo-
cated on different chromosomes can give rise to in-
distinguishable phenotypes when placed on the ap-
propriate genetic background. 
Environmental Factors in Diabetes Mellitus 
Environmental factors such as dietary intake,10 
gross obesity, 11 pregnancy, increased levels of estro-
gen in females, 12 and other endocrine changes have 
been correlated with onset of diabetes mellitus. Fi-
nally, infectious agents such as congenital rubella, 
group B coxsackieviruses, and mumps have also been 
shown to be associated with this syndrome. 13 There is 
good reason to believe that congenital rubella may 
lead to diabetes mellitus in up to 20% of children who 
have been infected in utero. 14 Similarly, mumps virus 
has long been recognized as a cause of pancreatitis in 
man, and scattered reports suggest that persistent 
diabetes mellitus may sometimes appear one to eight 
weeks after infection. 14·15 
Presently, three experimental models for virus-
induced diabetes have been reported in the literature. 
The first involves infection by an unknown virus in 
the guinea pig16; the second model involves the exper-
imental infection of mice with encephalomyocarditis 
(EMC) virus which specifically destroys B cells of the 
pancreas.13·11 - 19 Susceptibility appears to depend on 
genetic factors; some inbred strains are highly suscep-
tible and others are not. These data clearly demon-
strate that a viral agent belonging to the picornavirus 
group, can induce diabetes mellitus in susceptible 
animals. The third model system involves coxsackie-
virus B infection of the diabetic mutant mouse. Pres-
ently the best candidate for a causative viral agent of 
diabetes mellitus in man is coxsackievirus B. This 
agent has pancreatropic properties both in mice and 
humans20 and coxsackievirus B4 has been demon-
strated in both the exocrine and endocrine sections of 
the pancreas in human newborns with encephalo-
hepatomyocarditis .21 In addition, extensive epidemio-
logical studies have established a correlation between 
coxsackievirus B4 infection and acute-onset diabetes 
mellitus. 22 
Recent studies carried out by one of us have 
shown that the db mutation in the mouse causes a 
significant increase in susceptibility to coxsackievirus 
B4, and a dose-effect correlation between the virus 
and the diabetes mutation was evident. These obser-
vations were well supported by histopathological 
findings of the pancreata of animals infected with this 
virus (Table 2). 23 
These two animal models (EMC and coxsackie-
virus B4) involving picornavirus infection demon-
strate how genetic factors can interact with the envi-
ronment to cause diabetes. In the EMC virus model 
the nature of the genetic predisposition of the host is 
unknown, but is thought to be a recessive trait in-
volving more than one gene. 19·20 In contrast, the find-
ings in the mouse demonstrate that a single mutation 
at the db locus is responsible for the increased suscep-
tibility to diabetes in coxsackievirus B4 infection. 
Histocompatibility and Immune Factors in Diabetes 
Renewed support for the hypothesis that im-
mune mechanisms may have an etiological role in 
diabetes mellitus has been provided from the asso-
ciation between the histocompatibility antigens 
HLA-B8, WI 5, CW3, and HLA-D with diabetes mel-
litus.16·24- 27 The possibility that HLA-genes pre-
dispose the host to virus infection, resulting in B cell 
destruction and insulin-dependent diabetes has been 
suggested. Alternatively, the HLA-genes may be in-
volved in the induction of autoimmune responses, 
which again may have been triggered by virus infec-
tion.2·15·21 The latter alternative is supported by the 
observation that the diabetogenic HLA-08 marker 
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TABLE 2 
Coxsackievirus 84 Edwards Infection in the Inbred Diabetic and Normal C57BIKs Mouse 
% Mortality ofCB4' Infected Animal Histopathological Findings 
Virus Dose in PFU' Animal Pancreas Necrosis 
Islet Inflammatory 
Animal Genotype3 10' 10' 10' Acinar Islets Degran ulation Response 
db/ db JOO JOO JOO +4 +4 +4 
db/ + 10 50 90 + 4 +4 
+!+ JO JO 50 + I +4 
1 CB4E = Coxsackievirus B4 Edwards. 
2 PFU = plaque forming units. 
'C57 BI Ks inbred mice with the specific mutation were used. The db/ db animals displayed only chemical diabetes; food intake was 
monitored and regulated. 
has also been associated with an increase in autoim-
mune diseases.28 Finally, the evidence for, and signifi-
cance of, autoimmunity in diabetes is still highly de-
batable and little information on the regenerative 
properties or repair mechanisms of B cells is avail-
able. 
In summary, the evidence presented argues for 
genetic, environmental (viral), and immunological 
factors in diabetes mellitus. The complexity of the 
genetic factors in this syndrome is further emphasized 
by the heterogeneous nature of the disease itself, 
which may represent many different genetic entities. 
Insulin-dependent and insulin-independent diabetes 
mellitus may each be etiologically heterogeneous. 
Understanding of the interaction between genetic and 
environmental factors will permit the evaluation of 
their respective roles in the etiology of this syndrome. 
Table I is adapted from Renold et a11 and Hunt et al.' 
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Syndrome Identification 
What's in a name? This question is often asked 
of a genetic counselor when a syndrome is newly 
delineated. The brief case reports that follow demon-
strate the importance of establishing precise diag-
noses. They also emphasize that many of these syn-
dromes are recognizable only after careful physical 
examination of the proband and family members, 
consultation with other subspecialties (for example, 
neurology, radiology, orthopedics, dentistry, pathol-
ogy), and a review of the medical literature. 
While it is true that there usually is no treatment 
for the basic condition, complications can often be 
anticipated and serious consequences averted. Thus, 
the diagnosis of Pierre Robin anomalad forewarns 
SYNDROME IDENTIFICATION 
the physician of the risk of airway obstruction in the 
prone position and of feeding difficulties in early 
infancy. Knowledge of cervical spine anomalies in 
chondrodystrophy alerts the neurologist to central 
nervous system signs or symptoms that may result 
from basilar brain compression . 
A second benefit of syndrome identification is 
that a better prognosis regarding such important fac-
tors as longevity, morbidity, and ultimate adult 
height and mentality may be made. The dysmorphic 
infant with Saethre-Chotzen syndrome is not at sub-
stantial risk for mental retardation. Recognition of 
the earlier signs and dominant nature of the familial 
form of amyotrophic lateral sclerosis enables better 
counseling regarding longevity and morbidity. 
Knowledge of the mode of inheritance provides 
risk figures for recurrence so that family planning can 
be practiced. It is not sufficient to state that the 
patient with a dominant condition has a 50% risk that 
each offspring will inherit the disorder; as demon-
strated in the families with Pierre Robin anomalad 
and Saethre-Chotzen syndrome, some persons have 
179 
minimal manifestations, thus reducing the signifi-
cance of the existence of the condition. In the case of 
sex-linked diseases, as in the family with chondrodys-
trophy, identification of female carriers can establish 
a 50% risk that male offspring will inherit the dis-
order. Further studies in the family with ring 9 
chromosome abnormality should establish whether 
the proband, her mother, or other family members 
are at risk for bearing anomalous offspring. 
Often patients seen in our clinic have been eval-
uated elsewhere for one or more components (for 
example, short stature, dysmorphic features, mental 
retardation, congenital malformations) of their dis-
order, but a precise diagnosis has not been made. 
Identifying the syndrome provides a diagnosis and 
permits a proper focusing on the disease process. 
While evaluation is often time-consuming, the reward 
is a family gratified by the establishment of a diagno-
sis that will allow a better understanding of the condi-
tion. 
PETER MAMUNES, M.D . 
Professor of Pediatrics and of Human Genetics 
A Report of Familial Ring (9) Chromosome 
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Ring chromosomes ongmate in the simultane-
ous occurrence of two breaks at opposite ends of the 
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chromosome and the subsequent reuniting of the free 
ends to form a ring. They may be compatible with 
normal life, as only a fractional loss of genetic mate-
rial has occurred, or they may lead to spontaneous 
abortion or to an offspring with severe physical and 
mental handicap attributable to significant genetic 
alterations. 
The dearth of published case reports underscores 
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Figure-(Top left) Pedigree of the proband. (Bottom left) Proband's karyotype, showing the ring chromosome (9) (arrow). (Top right) 
Photograph of proband and mother. (Bottom right) Partial karyotype of proband's mother, showing the familial ring (9) (Chromosome 
magnification, X4000). 
the rarity of familial ring chromosomes. De novo ring 
chromosomes have been described in all chromosome 
groups in man, 1 but familial transmission of rings has 
been limited to chromosome 17,2 chromosome 18,3 
chromosome 21, Palmer et al4 and by E. Engel, MD 
(oral communication, May 1977), and a G-group 
chromosome not identified by banding analysis. 5 
Since the formation of a ring chromosome re-
sults in the loss of genes, it is not surprising that the 
phenotype of the individual possessing the ring can 
resemble the phenotype resulting from isolated short 
or long arm deletions, a combination of both, or 
duplications of the short or long arm due to recombi-
nation during meiosis. 
Case Reports 
Case I [Figure (top left , ll!,5) and (top right)] : P.S. was 
the product of a 28-week gestation of a 24-year-old para 1, 
gravida 1, abortion 0 mother who developed severe tox-
emia accompanied by a sudden decrease in estriol level. 
Because of fetal distress, a Caesarian section was per-
formed, and a 1,360 gm female was delivered on May I, 
1974. The baby sat alone at eight months, walked at 18 
months, and had a vocabulary of three to four words at 18 
months. Jn September 1975, she was referred by a pediatri-
cian to the Medical College of Virginia for evaluation of her 
failure to thrive. Her length was 28 cm, weight 6,914 gm, 
and head circumference 39 cm (all below the third percent-
ile); she showed slight bilateral epicanthal folds and normal 
ears. Other tests revealed a bone age of 12 months, normal 
skull films, 10/ 10 arches on dermatoglyphic analysis, nor-
mal intravenous pyelogram, normal sweat chloride, and a 
normal Denver Development Test. 
The patient was reexamined in the Genetics Counseling 
Clinic on March 10, 1976. At that time her developmental 
age on the Denver Development Test was 14 months (8 
months under chronological age), her vocabulary still con-
tained only four words, and she still was not toilet-trained. 
Examination revealed an alert, active female child with 
microcephaly, proportionate small size, large but not simple 
or low-set ears, pointed teeth, prominent nose, wide down-
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turned mouth, slight epicanthal folds, and no congenital 
heart defects. Her skull bones were fused. 
The patient returned to the Genetics Counseling Clinic 
at MCV on April 15, 1977, when she weighed 9,525 gm, 
with a height of 85 cm. Her vocabulary had increased to 
about 12 words and one three-word sentence. Thyroid stud-
ies showed T, , T,, and serum-free thyroxin to be within 
normal limits. 
Case 2 [Figure (top left, ll,5) and (top right) ]: C.S. is a 
27-year-old female and the mother of Case I. Her medical 
history includes an appendectomy at age 12 years, a kidney 
infection at 16 years, and scarlet fever at 17 years. Follow-
ing the birth of her first child, she elected to have a tubal 
ligation. On examination in April 1977, she appeared to be 
of average intelligence, had been graduated from high 
school, and was working as a processor at an electrical 
equipment plant. She was 149.87 cm tall and weighed 58.9 
kg. Dermatoglyphics were normal. 
CYTOGtNHIC STUDIES 
Case /: Peripheral blood lymphocytes were cultured in 
vitro using a slight modification of the method used by 
Moorhead et al.' Metaphase chromosomes were stained 
with the trypsin-Giemsa chromosome banding technique of 
Seabright.' Twenty randomly selected metaphases were 
counted, and a modal number of 46 chromosomes was 
established. Five cells were photographed and karyotyped 
and a large ring chromosome identified as chromosome 9 
was present in all cells. Chromosome-banding analyses es-
tablished the breakpoints at region 2, band 4 in the short 
arm (p24) and region 3, band 4 ( q34) in the long arm, 
indicating that the two breaks were near the terminus of the 
short and long arms, 46,XX,r(9)(p24;q34).' A representa-
tive karyotype is shown (Figure, bottom left). 
C(lse 2: At her own request, cytogenetic studies were 
done on the mother of the proband (11,5), the maternal 
grandparents (1 , I and 2), and the proband's father (11,6). 
Normal karyotypes were documented for the maternal 
grandparents and the proband's father; however, a ring 
chromosome (9) was found in all cells scored from duplicate 
peripheral blood cultures from the proband's mother. 
Chromosome banding analysis revealed her karyotype to be 
46,XX,r(9)(p24;q34 ). A partial karyotype is shown (Figure, 
bottom right). 
Discussion 
Two aspects of these cases are of particular inter-
est to the clinical geneticist and cytogeneticist. The 
first is the de novo origin of a ring chromosome in a 
mother with few, if any, phenotypic abnormalities; 
and second, the transmission of what appears, cyto-
genetically, to be the same ring chromosome-struc-
turally unaltered-to her daughter whose major 
physical defects are short stature and microcephaly 
associated with mental retardation. One could argue 
that the ring chromosome is responsible for the phe-
notype of the affected daughter, or that the ring (9) in 
the daughter and the associated phenotype are unre-
lated because the mother possesses the same ring. 
Ring chromosomes present the clinical geneticist 
with a challenging counseling problem be~ause many 
aspects of their behavior during meiosis remain ob-
scure. The way in which the ring chromosome partici-
pates in genetic recombination during meiosis, the 
occurrence or not of sister chromatid exchanges 
within the ring, and the subsequent genetic constitu-
tion of the ring will all determine whether a balanced 
or unbalanced gamete results. Although chromosome 
banding analysis allows the definitive identification of 
the involved chromosome and the accurate determi· 
nation of the points of breakage, genie determina-
tions await the refinement of the human gene map. 
It is possible that there is a tissue distribution 
difference of the ring (9) in the mother and daughter. 
Although only peripheral blood has been examined 
to date and no evidence of chromosome mosaicism 
documented, tissue mosaicism cannot be ruled out. 
We are aware of two other patients possessing a 
de novo ring (9) with break points identical to those 
in our family, (p24;q34), reported by Fraisse et al,9 
and by Y. Nakagome, MD et al (written communica-
tion, March 1976). There are many similarities be-
tween our patient and Nakagome's patient: propor-
tionate short stature, prominent nose, microcephaly, 
mental and motor retardation, and poor speech de-
velopment. The dermatoglyphic findings in our pa-
tient are of interest in that the finger pattern showed 
10/ 10 arches, similiar to the case report of Fraisse et 
al,9 but in contrast to Nakagome's patient in whom 
there was a high palmar triradius only. 
It is not possible to make definitive phenotype-
karyotype correlations based on three clinical cases, 
but the following observation can be considered. In 
our family, the proband's phenotype could result 
from genie alterations associated with the ring 
chromosome and the normal phenotype of the pro-
band's mother from a yet-to-be identified tissue mo-
saicism, or the contrasting phenotypes could be the 
result of the hemizygous expression of paternal reces-
sive alleles. It is also possible that only minor genetic 
changes occurred at the time of de novo ring forma-
tion which the mother inherited. Finally, the poten-
tial influence of ascertainment biases in a family of 
this type must always be considered. If, for whatever 
reason, the ring chromosome is consistent with phe-
notypes ranging from normal to severely affected, 
one would be much more likely to observe severely 
affected sporadic cases and mildly affected parents of 
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familial cases than to find severely affected parents 
with normal children. 
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The term amyotrophic lateral sclerosis (ALS) 
was first introduced by Charcot to describe cases with 
mixed upper and lower motor neuron signs without 
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sensory impairment.1 Later, th~ syndromes of pro-
gressive bulbar palsy (PBP) and progressive muscular 
atrophy (PMA) were recognized to be variations of 
the same pathological process, and ALS was used as 
an inclusive term to refer to these syndromes as well. 
Although some authors reserve the term ALS for the 
specific syndrome of mixed upper. and lower motor 
neuron lesions and use the term "motor neuron dis-
ease" to refer to the constellation of syndromes, most 
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e Affected () Passlllly lfflCtltl 
Fig I-Pedigree of proband and family members. 
* = Age at diagnosis 
• = Present age 
+ = Age at death 
of the literature on familial cases uses ALS as a 
generic title. We will adhere to this convention. 
Initially, the disease was thought to be sporadic, 
with a stable incidence of l in 100,000 population per 
year. In the early 1950s, reports appeared of a high 
incidence of ALS in the Chamorro Micronesians of 
Guam and on the Kii Peninsula in Japan.2 - 5 Studies 
suggested that at least some of the cases of ALS 
among Chamorros might be familial, and at about 
the same time familial cases began to be reported in 
Caucasian populations. 
Case Report 
Prohand: The proband (Fig I, III-2) is a 55-year-old 
white female with known maturity-onset diabetes, hypothy-
roidism, hypertension, and hepatosplenomegaly diagnosed 
as cirrhosis with fatty infiltration on liver biopsy, who pre-
sented with a three-year history of progressive weakness in 
her legs, causing difficulty in walking upstairs and rising 
from a chair. For one year, weakness increasingly impaired 
her ability to pick up objects, and her writing had become 
illegible. There had been no episodes of acute exacerbation 
or remissions. 
On examination, wasting and fasciculations of the 
tongue were noted, and her speech was slow and slurred, 
and the jaw jerk was hyperactive. There was weakness and 
wasting in the legs, and all reflexes were brisk with sustained 
ankle clonus, bilateral Hoffman signs, and bilateral positive 
Babinski responses. Sensation was normal in all modalities. 
VDRL, serum B12, cerebrospinal fluid (CSF), myelogram, 
and computerized axial tomography (CT) scans were all 
normal. An electromyogram (EMO) showed changes con-
sistent with ALS, especially in the C, and T, nerve root 
distributions. 
Other Family Members: It can be seen from the ped-
igree (Fig I) that the pro band's mother (II-3), maternal 
aunt (11-4), cousin (III-10), niece (IV-2), and two brothers 
(III-I , III-8) have all been diagnosed as having ALS. The 
age a.t onset has been variable, as has the duration of the 
disease in the different family members. 
The offspring of the proband are presently under inves-
tigation. The eldest son (IV-3) has definite upper motor 
neuron signs in the legs with brisk reflexes and bilateral 
Babinski responses which, combined with the family his-
tory, are highly suggestive of ALS. Two offspring (IV-4 and 
IV-5) show minimal signs of muscle wasting and slightly 
brisk reflexes. The diagnosis of ALS here is less certain, but 
the possibility exists that these two brothers are also af-
fected. The two youngest children (IV-6 and IV-7) show no 
sign of the disease. EMO studies may help establish a 
definite diagnosis in those family members at risk. 
Discussion 
Evidence for Heterogeneity in ALS 
There are three recognizable clinical forms of 
classical, sporadic ALS. In progressive bulbar palsy 
(PBP), muscles innervated by the medulla are pri-
marily affected. The presenting symptoms are dysar-
thria and dysphagia of insidious onset. The tongue 
atrophies and shows conspicuous fasciculations. Pa-
latal involvement is indicated by progressive speech 
difficulties and regurgitation of food through the 
nose. Whereas PBP is the result of a lower motor 
neuron (LMN) lesion, it is frequently accompanied 
by upper motor neuron (UMN) involvement of the 
cranial nerves leading to "pseudobulbar palsy." Here 
the tongue is again small but tends to be spastic, and 
the jaw, palatal, and pharyngeal reflexes are exagger-
ated. In addition, there is marked emotional )ability 
with attacks of inappropriate laughing or crying. 
In a second form of the disease, muscles in-
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nervated by the spinal nerves are primarily affected 
and UMN signs accompany those resulting from the 
lesions of the LMNs. Isolated UMN lesions are in-
dicated by spasticity and brisk reflexes with bilateral 
Babinski responses, whereas isolated LMN lesions 
present with muscle wasting, weakness, and fascicula-
tions with depressed or absent reflexes. The actual 
physical signs depend on the relative preponderance 
of UMN or LMN degeneration. 
In a third form, LMN lesions predominate re-
sulting in progressive muscular atrophy, but UMN 
lesions may occasionally be present. The symptoms 
and signs of LMN lesions are as described above and 
usually start in the hands and forearms. 
Although these three clinical presentations can 
be distinguished, all are thought to be variations of 
the same process. Sensory impairment is not found, 
although patients may complain of muscle cramps or 
abnormal sensations resulting from muscle fascicula-
tions. 
The diagnosis is usually made on clinical 
grounds, although the EM G shows characteristic 
patterns of denervation with fibrillation, fascicula-
tion, and giant action potentials indicating spontane-
ous activity. 
Pathologically, extensive neuronal loss is evident 
with astrocytic gliosis of the UMNs and LMNs as 
well as the lower cranial nuclei. Cytoplasmic and 
nuclear shrinkage occurs with excessive accumulation 
of lipofuscin. In Guamanian cases, additional fea-
tures include neurofibrillary degeneration of the or-
bital gyrus, Ammon horn, and basal ganglia. Gran-
ulovascular bodies are a lmost always present in the 
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pyramidal cells of Ammon horn where eosinophilic 
crystaloid inclusion bodies are also seen.6 
Although reports of familiai adult-onset ALS 
constitute only about 5% to 10% of the reported 
cases,7 at least 30 Caucasian families have been de-
scribed in which then:: appears to have been a domi-
nant mode of inheritance.8 - 16 
Among the Chamorros, nearly 50% of all re-
ported cases are familial; 17 however, extensive studies 
have failed to define a clear pattern of inheritance.7 It 
is possible that there may be a genetic predisposition 
to an environmental agent. 
It is still uncertain whether these three entities, 
sporadic, Guamanian, and fami lial ALS, represent 
one or several etiologically different diseases. All 
three present with indistinguishable symptoms of 
muscular atrophy, lateral sclerosis, and bulbar palsy. 
Dementia, often seen in affected Chamorros, also 
occurs in both familial and sporadic cases. 18 In-
volvement of the posterior columns has been de-
scribed in a small number of inherited ALS cases19 
but not with enough consistency to be distinctive. 
Other parameters may permit a clear distinction 
of the three types (Table l ). 
Sporadic ALS typically has a iate onset in the 
early 50s; the first signs usually appear in the upper 
extremities, and the disease has a short duration lead-
ing to death within five years. In contrast, a review of 
30 published Caucasian pedigrees indicates that fa-
milial cases more often have an onset in the early 
forties beginning in the lower extremities with a 
longer duration. Chamorro cases resemble familial 
ALS in onset and duration but are similar to sporadic 
TABLE I 
Comparison of Sporadic, Guamanian, and Familial ALS 
Sporadic Guamanian Familial 
Number of Number of Number of 
Based on Parameter value cases Parameter value cases Parameter value cases 
Age of onset, yrs 52.7 ± 2.7 JOO 46.1 ± 13. 1 62 42.7 ± 11.1 98 
Onset under 30 yrs 1% 100 8% 62 13.3% 98 
Duration, yrs 2.5 86 4 70 4.3 83 
Duration > 5 yrs 8.1 % 86 34.3% 70 36.5% 83 
Initial Site JOO 62 70 
Bui bar 25% 13% 18% 
Upper extremity 41 % 64% 26% 
Lower extremity 30% 20% 56% 
Other 4% 3% 0% 
Sex ratio: male: female 1.86: I 186 1.94: I 132 1.13: I 98 
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Fig 2-Cumulative distribution of age at onset in familial ALS. 
ALS in sex ratio and site of initial involvement. 17•20 
The Chamorro population on Guam appears to be 
intermediate in many respects between the familial 
and sporadic types. However, until the etiology of 
ALS is known, it will not be possible to classify these 
diseases with certainty. 
Genetic Counseling 
In this family, the pedigree suggests autosomal 
dominant transmission with complete penetrance, 
but in the absence of male-to-male transmission, a 
sex-linked dominant inheritance cannot be excluded. 
The genetic advice given to family members (consul-
tands) will depend on the presence or absence of signs 
of the disease and their relationship to individuals 
known to be affected. 
For example, a 47-year-old man, whose father 
has been diagnosed as having A LS, wants to know if 
he too will become affected and what is his risk of 
having an affected child. His a priori risk of having 
inherited the gene from his father is one half because 
of the dominant transmission of ALS. From a review 
of published familial cases, ALS appears to be a 
TABLE 2 
Bayesian Approach to Estimation of Genetic Risk 
Probability 
A priori 
Conditional 
Joint 
Posterior probability 
the consultand 
is affected 
Inherited the Not inherited 
disorder the disorder 
1/ 2 1/ 2 
1/ 4 I 
1/ 8 1/ 2 
1/ 8 
----- = 1/ 5 
1/ 8 + 1/ 2 
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strongly penetrant trait with nonpenetrance occur-
ring in only 3% of the cases. 18•2 1 Figure 2 depicts a 
cumulative distribution of the age of onset of familial 
ALS in 52 males and 46 females culled from the 
literature. Patients who do carry the gene have only a 
one-fourth probability of reaching the age of 4 7 with-
out manifesting the disease. The posterior or final 
probability that the consultand, age 47 with an af-
fected father but no symptoms himself, will develop 
ALS is one fifth or 20% (Table 2).22 The practical 
implication for genetic counseling is that the longer 
the consultand lives and is symptom free, the lower 
will be his risk of carrying the gene. 
Conclusion 
Familial conditions, such as ALS, Huntington 
chorea, dystrophia myotonica, polyposis coli, and the 
presenile dementias, in which individuals who carry 
the abnormal gene may not develop symptoms until 
late in the reproductive period, present difficult prob-
lems for the genetic counselor. Modification of the a 
priori probabilities by consideration of the age of the 
consultand, as described above, can make a consid-
erable difference to risk estimates. 
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A Case of Saethre-Chotzen Syndrome 
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Saethre-Chotzen syndrome was described inde-
pendently by the Norwegian psychiatrist, Saethre, 1 
and the German psychiatrist, Chotzen,2 in the 1930s; 
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since that time many cases have been reported, some 
using the terms acrocephalosyndactyly, type III, and 
craniooculodental syndrome. Clinically, the syn-
drome is characterized by premature closure of the 
cranial sutures, low-set hairline, nasal septum devia-
tion, brachydactyly, and ptosis.3 It is inherited as an 
autosomal dominant with complete penetrance and 
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Figure-(a) Skull x-ray at 6 months reveals difference in orbit size and asymmetric shape of skull. (b) Left profile shows abnormal 
placement of ear and flat nasal bridge. (c) Patient at 6 months has left-sided ptosis, dystopia canthorum, and short palpebral fissures. 
Face shows characteristic asymmetries with left side being affected. 
great variability in expression. Because of this vari-
able in expressivity, the syndrome is difficult to diag-
nose in the less severe form without a positive family 
history. 
Recently, an infant was admitted to the Medical 
College of Virginia newborn nursery who had many 
of the features of Saethre-Chotzen syndrome, as well 
as other findings which have rarely been reported in 
association with the syndrome. 
Case Report 
The patient is a black female infant who was born five 
weeks prematurely to a 17-year-old para 1, gravida 1 
mother and a 23-year-old father. She weighed 1,830 gm and 
had a 27.5 cm head circumference at birth. At four weeks, 
she was transferred to the MCV Hospital with Group B-
Beta streptococcal sepsis which was successfully treated 
with a ten-day course of penicillin and. gentamicin. On 
admission, she was noted to have facial asymmetries, ptosis, 
hypertonia and a probable ventricular septa! defect; she was 
referred for a genetics consultation. 
Her family was evaluated for stigmata of Saethre-
Chotzen syndrome. The child's father was unavailable for 
examination but was reported as having a face that was 
slightly asymmetrical with an under-developed left cranium 
and the left eye smaller than the right. These asymmetries 
were said to be more pronounced in childhood. The mother 
was examined and did not show any stigmata of the syn-
drome. No other family members were known to be af-
fected. 
The physical examination of the child revealed an acro-
cephalic skull with left-sided malar, frontal and anterior 
parietal bone hypoplasia, and microcephaly. Her face was 
asymmetric with left-sided ptosis; she had dystopia with 
generally small palpebral fissures, the left slit being shorter 
than the right. Her nasal bridge was flat, her ·nose had a 
broad tip and a long prominent philtrum, and her mouth 
was thin and down-slanting. The left ear was lower than the 
right and posteriorly rotated, but both ears were well 
formed. Her neck was short and displayed a decreased 
range of motion, though it appeared normal on x-rays. Her 
hips also displayed a 20 degree decrease in motion. She had 
two cafe-au-lait spots; one 2 X 3 cm on her back and one 2.5 
cm in diameter in the groin area. There was a sacral dimple 
on her lower back. She had a grade IV / VI systolic murmur, 
probably caused by a ventricular septa! defect. 
Her extremities were slightly asymmetrical with the 
right arm and leg 0.5 cm longer than the left. She had two 
dimples on either side of each elbow and knee, a peculiar 
long longitudinal skin crease along both inner calves, and 
mild hallux valgus. 
A dermatoglyphic analysis revealed an excess of whorls 
(six), one of which was a radial loop with a central pocket. 
She had an intermediate triradius. Both the a-b ridge count 
and the total finger ridge count were within normal limits. 
X-rays of her skull and hips in the neonatal period were 
read as normal except for a normal variant of a lilcken-
schadel deformity of the skull. Repeat x-rays of the skull at 
6 months showed I) cranial asymmetry with the left orbit 
smaller than the right, 2) coronal sutures that were patent 
but narrower than the other cranial sutures, and 3) a left 
temporal bone that was higher than the right (Figure-a). X-
rays of the cervicothoracic spine at that time were normal. 
Chromosome analysis showed a normal female karyotype, 
and her serum calcium of 11 mg/ 100 ml was normal at 6 
months. 
A follow-up examination at age 8'1i months showed all 
her physical measurements to be below the 3rd percentile 
with a length of 63 cm, weight of 13 lb 12 oz, and head 
circumference of 39.5 cm. She was generally hypertonic and 
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had poor head control. However, her motor milestones 
were not delayed; she was able to crawl and transfer objects 
from hand to hand by 8 months and sit without support at 
the age of 9 months. 
From these physical and radiological findings the diag-
nosis of SaethrecChotzen syndrome was made. 
Discussion 
The physical findings of 120 cases of Saethre-
Chotzen syndrome were compared by 0. A. Pantke 
et al. 4 In facial appearance the patients were strik-
ingly similar to each other and to our patient. More 
than 75% had ptosis, deviated septum, acrocephaly, 
and low-set frontal hairline. The facial asymmetries 
and unusual cranial contours in the syndrome prob-
ably result from premature closure of the coronal or 
sphenobasilar sutures. This may also account for the 
tear duct stenosis and the mild mental retardation 
which are occasionally found . Skull x-rays like the 
ones in this case are characteristic, showing pre-
mature closure of the sutures as well as asymmetries 
in bone and orbit size. Hypertelorism and dystopia 
canthorum are often observed. Optic atrophy may be 
an associated finding. 
The ears are frequently small and low-set, with 
folded pinnae. Conductive hearing loss is an occa-
sional finding. The palate is either high-arched or 
clefted. Dental anomalies such as missing teeth and 
peg-shaped or anomalous maxillary lateral incisors 
are important in differientating this syndrome from 
the other acrocephalies. 
The extremities may show mild syndactyly; 
brachydactyly is common. Clinodactyly and hallux 
valgus are sometimes noted. 
The cardiac defect our patient exhibits is rarely 
found in Saethre-Chotzen syndrome; however, it was 
reported in Chotzen's original cases and in several 
individuals of another kindred. 5 
The multitude ofassociated findings in this syn-
drome can not be explained on the basis of premature 
closure of the sutures alone, though this does account 
for m.any of the facial features. Other malformations 
such as the cardiac defect, dental anomalies, and 
defects of the extremities indicate that one gene has 
varied effects on many organ systems. 
Our case further documents the association of 
cardiac defects with Saethre-Chotzen syndrome while 
also demonstrating many of the characteristic find-
ings. The child's father probably represents a very 
mild expression of this dominantly inherited condi-
tion, demonstrating the wide variability of expression 
seen in this disorder. 
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A New Familial Chondrodystrophy 
Simulating Parastremmatic Dwarfism 
WENDY L. GOLDEN, Graduate Assistant, Department of Human Genetics 
PETER MAM UN ES, M.D., Professor of Pediatrics and of Human Genetics 
MICHAEL B. KODROFF, M.D., Assistant Professor of Radiology 
Recent developments in tissue culture and en-
zyme analysis have made it possible to classify more 
precisely some of the skeletal dysplasias and to un-
derstand their pathophysiology; thus almost all seven 
clinical types of mucopolysaccharidoses are due to 
separate single enzyme deficiencies-one type, the 
Sanfilippo syndrome, has three subtypes, each with a 
different enzyme deficiency.' The majority of the skel-
etal dysplasias have no definable biochemical abnor-
mality and are classified on the basis of clinical and 
radiological findings and the mode of inheritance. 
The purpose of this report is to present a family with 
an apparently new type of chondrodystrophy. 
Case Report 
Proband: An 18-year-old male with a diagnosis of Mor-
quio disease was brought to the Medical College of Virginia 
Genetic Counseling Clinic by his mother and sister. He was 
the product of a normal, uncomplicated pregnancy, labor, 
and delivery, and at birth was considered normal. At age 3 
to 4 months his mother states that he appeared to be behind 
in his development, although he was said to have had a 
three-word vocabulary at 5 months and at IO months could 
put three words together in a sentence. He was evaluated at 
2112 years and found to have mild kyphosis of the dorsolum-
bar region, moderate genu valgus, and slight restriction of 
internal and external rotation, and extension, of both hips; 
the sternum was rioted to be particularly prominent. Radio-
graphic examination showed slight diffuse changes of chon-
drodystrophy throughout, with the changes in the spine 
appearing more marked (Figure, b,f). He as unsuccessfully 
fitted with braces in an effort to make him ambulatory. 
This work was supported in part by Grant #9306-5124 from 
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The skeletal changes progressed and when first seen at 
the MCV Clinic in 1976, the patient was markedly dwarfed 
(length 36 1/2 inches), with coarse facies showing hyper-
telorism, a flat, wide nasal bridge, anteverted nostrils, a lack 
of cartilage in the nose and ears, heavy eyebrows; stra-
bismus, and searching nystagmus. There .was no corneal 
clouding. There were marked contractures of the limbs with 
limited movement in all directions of the knees and hips. 
The wrists were thickened but otherwise normal. The fingers 
were hyperextensible and the metacarpal' joints appeared 
enlarged. Extension of the left elbow was nearly normal, 
while the right elbow had a 20 degree limitation of exten-
sion. All of the joints appeared knobby and enlarged, accen-
tuated by the thinness of the extremities (Figure, e). There 
was severe kyphosis with mild thoracolumbar scoliosis and 
the sternum protruded anteriorly to a very marked degree 
(Figure, d). Also noted were signs of trunk and upper-
extremity ataxia. While in the hospital he showed marked 
difficulty in breathing, with wheezing and congestion. There 
was no hepatosplenomegaly nor an abnormality of the pal-
ate. 
There appeared to be moderate psychomotor retarda-
tion with disproportionate speech impairment, but men-
tation was difficult to assess due to the difficulty in speech 
and the lack of formal education. 
The skeletal survey revealed marked kyphoscoliosis of 
the entire spine with a universal platyspondylia without 
anterior beaking of the vertebral body. The end plates were 
markedly irregular with lacelike ossifications. No evidence 
of rhizomelia could be demonstrated. There were marked 
changes about the knees with flaring of the metaphyses and 
marked irregularities of the ossification centers, both me-
taphyseal and epiphyseal, with the same lacelike ossification 
seen in the spine (Figure, g). Films of the pelvis revealed 
shortening of the ilium bilaterally, with the same irregular 
lacelike ossification bordering the iliac bones and around 
the joint spaces (Figure, c). Marked deformities were present 
in the feet. All of the actively growing centers showed the 
same type of changes as the knees. There was no significant 
bowing of the long bones. The skull showed a marked 
thickening of the calvarium, both over the convexities of the 
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Figure-(a) Pedigree of family. (b.c) Pelvic x-rays of pro band showing dramatic changes from 21/2 to 18 years, with development of a lacelike 
ossification pattern. (d,e) Clinical appearance ofproband at 18 years. (f.g) X-rays of knees at 21/2 and 18 years. Note the development of 
marked flaring of epiphyses and metaphyses and lacelike ossification. 
skull and at the base. A midline tomogram revealed the 
presence of basilar impression. These findings were felt to 
be inconsistent with a diagnosis of Morquio disease or any 
other spondylometaphyseal dysplasia. 
Blood studies on the proband showed no unusua l find-
ings except for mild borderline anemia and an increase in 
platelets. An SMA 6 was within normal limits. SMA 12 was 
normal except for an increase in alkaline phosphatase. Uri-
nalysis was within normal limits. An electrocardiogram 
showed a generalized grade I dysrhythmia, but the study 
was reported to be a technically difficult recording due to 
movement. Hearing sensitivity was within normal limits, 
with a bilateral 20-decibel hearing loss. A pulmonary lab 
report noted the presence of severe hypoxemia and moder-
ate metabolic acidosis which was uncompensated. 
An enzyme analysis of skin fibroblasts, (courtesy Dr. 
Thaddeus Kelley), showed normal levels of fucosidase, 
mannosidase. /3-galactosidase, hexosaminidase, arylsu!fa-
tase, and a-iduronidase. On two runs of radioactive sulfate 
accumulation the cultures from the proband were similar to 
the controls. 
Other Family Members: An investigation of the family 
history revealed two other relatives, a brother and a mater-
nal uncle, who appear to have had the same disease as the 
proband (Figure, a). Further, it appears that the proband's 
mother is mildly affected, and a maternal aunt and maternal 
grandmother may show minor signs of the disease. 
The proband's brother was born in 1954 after a nor-
mal, uncomplicated pregnancy, labor, and delivery. H~}t!t 
alone at 6 months, but walking was delayed until 18 morit_H§ 
and even then he had trouble with his balance. A diagnosis 
of rickets was made at about 1 to 2 years of age and he was 
admitted to a children's hospital in 1958 for evaluation of 
his deformities. Physical examination revealed severe ky-
phosis in the low dorsal and upper-lumbar spine and 
marked genu valgus with enlargement of the knee joints. 
Motion through the hip joints was slightly restricted in 
external and internal rotation and in extension. The radiol-
ogist's report stated that there was " generalized disease of 
cartilaginous development," and that the changes seen were 
consistent with a diagnosis of Morquio disease. The patient 
was seen again in 1961 at which time he was ambulatory; 
however, the deformities about the knees had increased as 
h_ad the ky~hosis. He was attending school and was re-
ported .tb be doing well. A physical examination following 
admission to a hospital for respiratory stridor in 1970 noted 
him to be a grossly skeletally deformed dwarf (height 40 in; 
weight 60 lb), with coarse facies, ocular hypertelorism, flar-
ing of the alae nasae, saddle nose, pectus carinatum, and 
marked kyphoscoliosis. There was darting nystagmus but 
no corneal clouding. He was treated unsuccess.fully with 
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aminophylline and died three days after admission, the 
cause of death being listed as terminal cardiorespiratory 
failure with interstitial pneumonia of viral etiology. 
The proband's mother is a 51 -year-old woman with 
coarse features and difficulty in walking. Her height is 62 in. 
Radiographs in 1976 showed mild degenerative changes in 
the distal phalanges of the hand and in the body of T-12 as 
well as partial collapse of the latter. Accentuated lordosis of 
the lumbosacral spine was noted with anterior lipping and 
mild degenerative changes. There was deformity of the feet 
with pes cavus bilaterally. The long bones showed early 
degenerative changes about the hips. The iliac bones were 
shortened and there was flattening of the acetabular roof. 
These changes were similar to, but much less severe than, 
those found in her son. 
The proband's mother reported that she had had a 
brother, born in 1929, who was affected similarly to her two 
sons. He appears to have followed the same clinical collrse 
and died in 1950, reportedly from the same type of illness as 
his deceased nephew. 
Also noted in the family history is a maternal aunt who 
walks with difficulty, although she is reported to be of 
normal height; the maternal grandmother has the same type 
of walking difficulty. The proband's two sisters, who have 
two different fathers, are of normal height and appearance 
and present a striking contrast to their mother. 
The family history is very suggestive of X-linked inher-
itance, with the males being affected more severely than the 
females. 
Discussion 
On the basis of radiographic, biochemical, and 
ophthalmologic findings, Morquio disease and the 
other mucopolysaccharidoses were eliminated fro'm 
the diagnosis.' Of the spondyloepiphyseal dyspla~j4~ 
(SED),2 SEO congenita, and SEO tarda anq SQf 
tarda brachyolmia type were considered. SEQ cq[]~ 
genita is an autosomal dominant in which the".gefor-
mities are present at birth and it is further differenti-
ated from this case by its characteristic presence of 
rhizomelia and retinal detachment. SEO tarda is a 
relatively mild form of X-linked recessive dwarfism in 
which the age of onset is between 5 to I 0 years of age. 
SOT brachyolmia is also a mild form of dwarfism in 
which the skeletal deformities are not consistent with 
the radiographic findings in this case. None of the 
mucopolysaccharidoses nor the SEDs show the strik-
ing lacelike ossification described in our patient. 
Parastremmatic dwarfism3·' was considered be-
cause of the distinctive Iacelike ossification of the 
bones; however, in a written communication, in Feb-
ruary, 1977, with Dr. Langer, who first described 
parastremmatic dwarfism, it was noted that our pa-
tient did not have the classic twisting or bowing of the 
long bones. The essentially normal configuration of 
the proximal femora and the type of changes seen in 
the vertebral bodies differentiate this case from para-
stremmatic dwarfism which is considered to be an 
autosomal dominant disease. 
We feel that this patient represents an X-linked 
form of dwarfism, not previously described, which is 
characterized by coarse facies, severe skeletal defor-
mities involving nearly all bones, and a distinctive 
lacelike ossification of the iliac bones, the end plates 
in the spine, and the epiphyses and metaphyses of the 
knees and elbows. In such cases neurologic and car-
diopulmonary complications lead to. demise in late 
adolescence or early adulthood. 
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Familial Occurrence of Pierre Robin 
Anomalad 
WENDY 0. SEGRETI, M.A., Graduate Assistant, Department of Human Genetics 
PETER MAM UN ES, M.D., Professor of Pediatrics and of Human Genetics 
The Pierre Robin anomalad is a congenital de-
fect consisting of micrognathia, glossoptosis, and 
cleft palate. While these three stigmata represent the 
classical triad of anomalies first described by Pierre 
Robin in 1923,1 less severe forms of the anomalad are 
seen with a variable expression of the microsigns of 
the disease. Dennison2 suggests that the determina-
tion of exactly what constitutes a mild degree of 
Pierre Robin anomalad is a subjective matter. While 
cleft palate is commonly present, it may sometimes be 
replaced by a high-arched pahite. He reports that 
radiography shows that there is a short mandibular 
body joining the ramus at a more acute angle than 
normal. The more severe cases can lead to respiratory 
obstruction and death. Anatomically, the defect is 
q4ite clear; th~ body of the mandible is posteriorly 
displaced causing the tongue to block normal respi-
ratory and alimentary pathways. 
No mode of inheritance has yet been clearly 
established. While the majority of cases of this rare 
disorder (I :50,000 births )3 appear to be sporadic, 
there have been several reports of familial occur-
rence; cases of affected brothers have been presented4• 
5 and an X-linked subvariety exhibiting persistence of 
the left superior vena cava and atriill septa) defect has 
been described.6 A family having maternal half-sib-
lings with the Pierre Robin anomalad is reported 
here. The mother bore a single affected male and four 
normal females by her first husband and two affected 
females by her second husbanq. Strong evidence ex-
ists for dominant transmission through the mother, 
who herself exhibits mild characteristics of the dis-
Correspondence and reprint requests to Wendy 0. Segreti , 
Box 33, Medical 'college of Virginia, Richmond, Virginia 23298. 
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order. We therefore propose that this family repre-
sents an autosomal dominant form of the Pierre 
Robin anomalad with variable expressivity. 
Case Report 
I 
][ 
The proband (Fig I , III,!) was born on July 22, 1976, 
of a 26-year-old mother and a 25-year-old father. She was 
the 8 pound IO V2 ounce full-term product of a pregnancy 
complicated by maternal vaginal discharge which was 
treated with a cream and resolved in the second trimester, 
and leaking of a mniotic fluid with spontaneous resolution 
from the fourth through the sixth months. The patient was 
born by a normal vaginal delivery, cried immediately, and 
did not need resuscitation. Midline cleft palate and micro-
gnathia were noted at birth, with the lips intact. Other than 
two left preauricular skin tags and possible bilateral high 
frequency hearing loss, no other abnormalities were pre-
sent. She breathed rapidly and became cyanotic when al-
lowed to lie flat on her !Jack with resulta nt backward dis-
placement of the tongue. Postnatal jaundice was treated 
with phototherapy. She was discharged with special feeding 
instructions, but readmitted a month later due to poor 
weight gain. At two months she was noted to have a grade I 
e Affected Minor manifestations 
Fig I-Pedigree of pro band's family showing affected half-siblings. 
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Fig 2-Lateral x-ray of proband's mother showing steep mandibu-
lar angle. 
to II/VI systolic ejection murmur, but chest x-ray, elec-
trocardiogram, a nd a cardiology consultation suggested 
that there was no organic heartdisease present. The patient 
was hospitalized many times during the first months of life 
due to multiple episodes of pneumonia and the inability to 
maintain adequate nutrition. At age 7 months a tra-
cheostomy was done which resulted in improved breathing 
and weight gain. At age 11 months the patient was admitted 
for bronchoscopy and removal of the tracheostomy tube; 
she was unable to breathe adequately without it, and the 
tube was reinserted. She died suddenly at the age of one 
year, but no postmortem examination was permitted. 
The proband's sister (Fig I , IIl ,2), also affected with 
Pierre Robin a nomalad, died two months after birth as a 
result of poor weight gain a nd a terminal bout of aspiration 
pneumonia. Their half-brother (Fig I, III ,3), who died 28 
days after birth, had severe congenital heart disease, includ-
ing persistent left superior vena cava, tricuspid atresia, 
atrial septa! defect, right-sided aortic arch, and descending 
aorta in addition to the Pierre Robin anomaly. Of the four 
normal half-sisters of the proband (Fig I , III,4,5,6,7), two 
have slightly high , narrow palates and small chins. The 
mother has a very high-arched palate and micrognathia. A 
lateral x-ray of the mother's jaw demonstrated that one 
ma ndibular ramus was smaller and narrower than the 
other, presenting as asymmetrical appearance, a nd the 
mandibular angle was steeper than normal (Fig 2). 
Discussion 
We have presented a family in which three chil-
dren (I male and 2 females) who had two different 
fathers were affected with the Pierre Robin anoma-
lad. The mother exhibits some of the characteristic 
stigmata of this syndrome which strongly suggests 
that an autosomal dominant form of the Pierre 
Robin anomalad exists with variable expressivity. 
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A service to medical education from A. H. Robins: !'~'-' Excerpted from Volume 2 
oflheG.I. 
Sen es 
on physical examination 
of the abdomen: 
Normally palpable organs: 
the edge of the liver descending, 
on inspiration, below the costal 
margin (A); the lower pole of the 
right kidney (B); the abdominal 
aorta (CJ ; the descending colon 
and the sigmoid (D); the ascend-
ing colon (E); and occasionally 
the bladder (though rising of 
this organ beyond the pubis 
does not necessarily indicate 
disease). 
Impossible to outline, unless 
diseased, distended or enlarged: 
the gallbladder, pancreas, 
stomach, small intestine, trans-
verse colon and spleen. 
:I The A H Robins G I Series consists of six book-lets, designed to provide a quick, yet comprehen- ! "f sive review of basic procedures and practices 1n k 1, 
G .I. medicine - with particular emphasis on the ~ 
physical examination as performed 1n the office or ' :;:. 
at bedside. If you have teaching respons1b1l1t1es. . ""' 
limited quantities are available: Part 1 - Inspection, ., ···~ 
Part 2-Palpation, Part 3 - Percussion, Part 4 - Auscultation. Part 5 -
Abdominal Pain and Part 6-Differential Diagnosis of Abdominal 
Disorders. Write to: The Medical Department, A. H . Robins Company, 
1407 Cummings Drive . Richmond , Virginia 23220. 
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G .I. med icine - wi th part icu lar emphasis on the 
p hysica l examinati o n as pe rfo rmed in the office or !... ~ 
at bedside. If you have teac hi ng respo nsibi li ties ' ...... 
limited quantities are avai lable: Part 1 - Inspection. .. .... , 
Part 2 - Palpation . Part 3 - Percussion . Part 4 - Auscultation. Part 5 -
Abdominal Pain and Part 6 - Different1al D iagnosis of Abdominal 
Disord ers. Write to: The M edica l Depa rtme nt. A. H . Robins Company, 
1407 Cum m ings Dr ive . Ric hmond . Vi rg inia 23220. 
each tablet. 
capsule or 5 cc . 
teaspoonful 
of elixir (23% alcohol) 
hyoscyamine sulfate 0.1037 mg. 
atropine sulfate 0.0194 mg. 
hyoscine hydrobromide 0.0065 mg. 
each 
Don natal 
No. 2 
0.1037mg. 
0.0194 mg. 
0.0065mg. 
phenobarbital (V. gr.) 16.2 mg. (Y.! gr.) 32.4 mg. 
(warning· may be habit forming) 
each 
Extentab 
o.3111 mg. 
0.0582mg. 
0.0195mg. 
C'X gr.) 48.6 mg. 
Brief sum~ary. Adverse Reactions: Blurring of vision. dry mouth, 
difficult urination, and flushing or dryness of the skin may occur 
on higher dosage levels, rarely on usual dosage. Contraindica-
tions: Glaucoma: renal or hepatic disease: obstructive uropathy 
(for example, bladder neck obstructiori due to prostatlc hyper-
trophy); or hypersensitivity to any of the ingredients. 
A·H·ROBI NS A H. Robins Company. Richmond, Virginia 23220 
each tablet. 
capsule or 5 ml 
(tsp.) of elixir 
(23% alcohol) 
Phenobarbital ( Y• gr) 16.2 mg 
[warning: may be habit forming) 
Hyoscyamine sulfate 0. 1037 mg 
Atropine sulfate 0.0194 mg 
Hyoscine hydrobromide 0.0065 mg 
A·H·ROBINS 
each 
Don natal 
No. 2 Tablet 
[ Y2 gr) 32.4 mg 
0.1037mg 
0 .0194 mg 
0.0065mg 
AH. Robins Company, Richmond, Virginia 23220 
Indications: Based on a review of this drug by the NAS/NRC 
and/ or other information. FDA has classified the following indica-
tions as possibly effective: adjunctive therapy in the treatment of 
peptic ulcer: the treatment of the irritable bowel syndrome (irrifaole 
colon, spastic colon, mucous colitis) and acute enterocolitis. · 
Final classification of the less-than~eflective indications requires 
further investigation. 
Brief summary. Contraindicated in patients with glaucorna, renal or 
hepatic disease, obstructive uropathy (for example, bladder neck 
obstruction due to prostatic hypertrophy) or a hypersensitivity to any of 
the ingredients Blurred vision. dry mouth·, difficult urination, and · 
flushing or dryness ofthe skin may occur at higher dosage level.s, rarely 
at the usual dosage. '"' 

